TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.10 DEFINITIONS
Section 690.10 Definitions
"Acceptable
Laboratory" − A laboratory that is certified under the Centers for
Medicare and Medicaid Services, Department of Health and Human Services,
Laboratory Requirements (42 CFR 493), which implements the Clinical Laboratory
Improvement Amendments of 1988 (42 U.S.C. 263).
"Act" – The Department
of Public Health Act of the Civil Administrative Code of Illinois [20 ILCS
2305].
"Airborne Precautions"
or "Airborne Infection Isolation Precautions" – Infection control
measures designed to reduce the risk of transmission of infectious agents that
may be suspended in the air in either dust particles or small particle aerosols
(airborne droplet nuclei (5 µm or smaller in size)) (see Section
690.20(a)(7)).
"Arboviral Infection or
Disease" – Diseases caused by infection from a group of RNA viruses that
are transmitted to humans from the bite of infected blood-sucking arthropods,
including ticks, mosquitoes, sandflies and biting midges with clinical
manifestations ranging from mild febrile illness to severe encephalitis.
"Authenticated
Fecal Specimen" − A specimen for which a public health authority or
a person authorized by a public health authority has observed either or both
the patient producing the specimen or conditions under which no one other than
the case, carrier or contact could be the source of the specimen.
"Bioterrorist
Threat or Event" – The intentional use of any microorganism, virus,
infectious substance or biological product that may be engineered as a result
of biotechnology, or any naturally occurring or bioengineered component of any
microorganism, virus, infectious substance, or biological product, to cause
death, disease or other biological malfunction in a human, an animal, a plant
or another living organism.
"Business"
− A person, partnership or corporation engaged in commerce, manufacturing
or a service.
"Carbapenem
Antibiotics" – A class of broad-spectrum beta-lactam antibiotics.
"Carrier"
− A living or deceased person who harbors a specific infectious agent in
the absence of discernible clinical disease and serves as a potential source of
infection for others.
"Case"
− Any living or deceased person having a recent illness due to a notifiable
condition.
"Confirmed Case" – A
case that is classified as confirmed in accordance with federal or State case
definitions.
"Probable Case" −
A case that is classified as probable in accordance with federal or State case
definitions.
"Suspect Case" − A
case whose medical history or symptoms suggest that the person may have or may
be developing a communicable disease or notifiable condition and who does not
yet meet the definition of a probable or confirmed case in accordance with
federal or State case definitions.
"CDC"
– Centers for Disease Control and Prevention.
"Certified Local Health
Department" − A local health authority that is certified pursuant to
Section 600.210 of the Certified Local Health Department Code (77 Ill. Adm.
Code 600).
"Chain of Custody"
− The methodology of tracking specimens for the purpose of maintaining
control and accountability from initial collection to final disposition of the
specimens and providing for accountability at each stage of collecting,
handling, testing, storing, and transporting the specimens and reporting test
results.
"Child Care Facility"
− A center, private home, or drop-in facility open on a regular basis
where children are enrolled for care or education.
"Cleaning"
− The removal of visible soil (organic and inorganic material) from
objects and surfaces, normally accomplished by manual or mechanical means using
water with detergents or enzymatic products.
"Clinical Materials" – A
clinical isolate containing the infectious agent, or other material containing
the infectious agent or evidence of the infectious agent.
"Closure" – A selective
restriction on, limitation to, or denial of entry to an area, building, or part
of an area or building, or the stoppage or suspension of operations, services
or activities within an area, building or business or part of an area, building
or business where persons are exposed to, infected with, or reasonably
suspected to be infected with, a notifiable disease, or to prevent transmission
of a notifiable disease or condition among a vulnerable population.
"Closure, Modified" – A
selective, partial restriction on, limitation to, or denial of entry to an
area, building, or part of an area or building, or the stoppage or suspension
of operations, services or activities within an area, building or business or part
of an area, building or business where persons are exposed to, infected with,
or reasonably suspected to be infected with, a notifiable disease or condition,
or to prevent transmission of a notifiable disease or condition among a
vulnerable population. Modified closure is designed to meet particular
situations and includes, but is not limited to, limiting or discontinuing
admissions, closing a specific area, discontinuing a medical procedure or use
of a medical device, or ceasing food production or serving a particular
implicated food product.
"Cluster" – Two or more
persons with a similar illness or condition, usually associated by place or
time, unless defined otherwise in Subpart D.
"Communicable
Disease" – An illness or condition caused by an infectious agent or its
toxins that occurs through the direct or indirect transmission of the
infectious agent or its products from an infected individual or via an animal,
vector or the inanimate object or environment to a susceptible animal or human
host.
"Contact"
− Any person known to have been sufficiently associated with or exposed
to a case or carrier of a communicable disease to have been the source of
infection for that person or to have been sufficiently associated with the case
or carrier of a communicable disease to have become infected by the case or
carrier; and, based on the knowledge of disease transmission, there is a risk
of the individual contracting the infectious disease. A contact can be a
household or non-household contact.
"Contact Precautions" –
Infection prevention and control measures designed to reduce the risk of
transmission of infectious agents that can be spread through direct contact
with the suspected or known case or indirect contact with potentially
infectious items or surfaces (see Section 690.20(a)(7)).
"Contagious Disease" –
An infectious disease that can be transmitted from person to person by direct
or indirect contact.
"Dangerously Contagious or
Infectious Disease" − An illness due to a specific infectious agent
or its toxic products that arises through transmission of that agent or its
products from an infected person, animal or inanimate reservoir to a
susceptible host, either directly or indirectly through an intermediate plant
or animal host, a vector or the inanimate environment, and may pose an imminent
and significant threat to the public health, resulting in severe morbidity or
high mortality.
"Decontamination" −
A procedure that removes pathogenic microorganisms from objects so they are
safe to handle, use or discard.
"Department"
− The Illinois Department of Public Health or designated agent.
"Diarrhea"
− The occurrence of three or more loose stools within a 24-hour period.
"Director" − The
Director of the Department, or his or her duly designated officer or agent.
"Disinfection"
− A process, generally less lethal than sterilization, that eliminates
virtually all recognized pathogenic microorganisms, but not necessarily all
microbial forms (e.g., bacterial spores).
"Droplet Precautions" –
Infection prevention and control measures designed to reduce the risk of
transmission of infectious agents via large particle droplets that do not
remain suspended in the air and are usually generated by coughing, sneezing, or
talking (see Section 690.20(a)(7)).
"Electronic Disease
Surveillance System" or "EDSS" − A secure, web-based
electronic disease surveillance system utilized by health care providers,
laboratories and State and local health department staff to report notifiable diseases
and conditions, and to collect and analyze additional demographic,
epidemiological and medical information for surveillance purposes and outbreak
detection and response.
"Electronic Laboratory
Reporting (ELR)" – The electronic transmission from laboratories to public
health of laboratory reports which identify notifiable diseases and conditions.
"Electronic Case Reporting
(eCR)" – The automated, real-time exchange of case report information
between electronic health records (EHRs) and public health agencies of notifiable
diseases and conditions.
"Emergency" – An
occurrence or imminent threat of an illness or health condition that:
is believed to be caused by any of
the following:
bioterrorism;
the appearance of a novel or
previously controlled or eradicated infectious agent or biological toxin;
a natural disaster;
a chemical attack or accidental
release; or
a nuclear attack or incident; and
poses a high probability of any of
the following harms:
a large number of deaths in the affected
population;
a large number of serious or
long-term disabilities in the affected population; or
widespread exposure to an
infectious or toxic agent that poses a significant risk of substantial future
harm to a large number of people in the affected population.
"Emergency
Care" − The performance of rapid acts or procedures under emergency
conditions, especially for those who are stricken with sudden and acute illness
or who are the victims of severe trauma, in the observation, care and counsel of
persons who are ill or injured or who have disabilities.
"Emergency
Care Provider" – A person who provides rapid acts or procedures under
emergency conditions, especially for those who are stricken with sudden and
acute illness or who are the victims of severe trauma, in the observation, care
and counsel of persons who are ill or injured or who have disabilities.
"Enhanced Barrier
Precautions" – An infection prevention and control intervention designed
to reduce transmission of antimicrobial resistant organisms that employs
targeted gown, glove, and other personal protective equipment use during high
contact resident care activities.
"Epidemic"
− The occurrence in a community or region of cases of a communicable
disease or condition (or an outbreak) clearly in excess of expectancy.
"Exclusion"
– Removal of individuals from a setting in which the possibility of disease
transmission exists. For a food handler, this means to prevent a person from
working as an employee in a food establishment or entering a food establishment
as an employee.
"Extensively
Drug-Resistant Organisms" or "XDRO" – A pathogen that is
difficult to treat because it is non-susceptible to all or nearly all antimicrobials.
"Fever"
– The elevation of body temperature above the normal (typically considered
greater than or equal to 100.4 degrees Fahrenheit).
"First
Responder" – Individuals who in the early stages of an incident are
responsible for the protection and preservation of life, property, evidence,
and the environment, including emergency response providers as defined in
section 2 of the Homeland Security Act of 2002 (6 U.S.C. 101), as well as
emergency management, public health, clinical care, public works, behavioral
health, and other skilled support personnel (such as equipment operators) that
provide immediate support services during prevention, response, and recovery
operations.
"Food
Handler" − Any person who has the potential to transmit foodborne
pathogens to others from working with unpackaged food, food equipment, clean
utensils, oral medications, or food-contact surfaces; any person who has the
potential to transmit foodborne pathogens to others by directly preparing or
handling food drinks, or providing oral medications or oral care. Food handler
does not include individuals in private homes preparing or serving food for
individual family consumption.
"Health
Care" – Care, services and supplies related to the health of an
individual. Health care includes preventive, diagnostic, therapeutic,
rehabilitative, maintenance or palliative care, and counseling, among other
services. Health care also includes the sale and dispensing of prescription
drugs or devices.
"Health Care Facility"
− Any institution, building or agency, or portion of an institution,
building or agency, whether public or private (for-profit or nonprofit), that
is used, operated or designed to provide health services, medical treatment or
nursing, rehabilitative or preventive care to any person or persons. This
includes, but is not limited to, ambulatory surgical treatment centers, home
health agencies, hospices, hospitals, end-stage renal disease facilities,
long-term care facilities, medical assistance facilities, mental health
centers, outpatient facilities, public health centers, rehabilitation
facilities, residential treatment facilities, school health offices, medical spas,
and adult day care centers.
"Health
Care Provider" – Any person or entity who provides health care services,
including, but not limited to, hospitals, medical clinics and offices, certified
midwives, long-term care facilities, medical laboratories, physicians,
pharmacists, dentists, physician assistants, nurse practitioners, nurses,
paramedics, emergency medical or laboratory technicians, and ambulance and
emergency workers.
"Health
Care Worker" − Any person who is employed by, volunteers his or her
services to or learning in a student or trainee role at a health care facility
to provide direct personal services to others. This definition includes, but
is not limited to, physicians, dentists, nurses and nursing assistants.
"Health
Information Exchange" – The mobilization of healthcare information
electronically securely across organizations within a state, region, community
or hospital system; or, for purposes of this Part, an electronic network whose
purpose is to accomplish the exchange, or an organization that oversees and
governs the network.
"Health
Level Seven" – Health Level Seven International or "HL7" is a
not-for-profit, American National Standards Institute (ANSI)-accredited
standards developing organization dedicated to providing a comprehensive
framework and related standards for the exchange, integration, sharing and
retrieval of electronic health information that supports clinical practice and
the management, delivery and evaluation of health services. HL7 produces
standards for message formats, such as HL7 2.5.1, that are adopted for use in
public health data exchange between health care providers and public health.
"Immediate
Care" – The delivery of ambulatory care in a facility dedicated to the
delivery of medical care outside of a hospital emergency department, usually on
an unscheduled, walk-in basis. Immediate care facilities are primarily used to
treat patients who have an injury or illness that requires immediate care but
is not serious enough to warrant a visit to an emergency department.
"Incubation Period" –
The time interval between initial contact with an infectious agent and the
first appearance of symptoms associated with the infection.
"Infectious Disease" – A
disease caused by a living organism or other pathogen, including a fungus,
bacteria, parasite, protozoan, prion, or virus. An infectious disease may, or
may not, be transmissible from person to person, animal to person, or insect to
person.
"Infection
preventionist" – A person designated by a hospital, nursing home, medical
clinic, or other health care facility as having responsibility for prevention,
detection, reporting, and control of infections within the facility.
"Institution" – An
established organization or foundation, especially one dedicated to education,
public service, or culture, or a place for the care of persons who are
destitute, disabled, or mentally ill.
"Institutions of Higher
Education" – Any place and/or building, or portion thereof, that offers or
is intended to provide post-secondary education, including colleges and
universities.
"Isolation" – The
physical separation and confinement of an individual or groups of individuals
who are infected or reasonably believed to be infected with a contagious or
possibly contagious disease from non-isolated individuals, to prevent or limit
the transmission of the disease to non-isolated individuals.
"Isolation,
Modified" – A selective, partial limitation of freedom of movement or
actions of a person or group of persons infected with, or reasonably suspected
to be infected with, a contagious or infectious disease. Modified isolation is
designed to meet particular situations and includes, but is not limited to, the
exclusion of children from school, the prohibition or restriction from engaging
in a particular occupation or using public or mass transportation, or
requirements for the use of devices or procedures intended to limit disease
transmission.
"Isolation Precautions"
– Infection control measures for preventing the transmission of infectious
agents, i.e., standard precautions, airborne precautions (also known as
airborne infection isolation precautions), contact precautions, droplet
precautions and transmission-based precautions (see Section 690.20(a)(7)).
"Law" – The Department
of Public Health Powers and Duties Law of the Civil Administrative Code of
Illinois [20 ILCS 2310].
"Least Restrictive"
− The minimal limitation of the freedom of movement and communication of
a person or group of persons while under an order of isolation or an order of
quarantine, which also effectively protects unexposed and susceptible persons
from disease transmission.
"Local
Health Authority" − The health authority (i.e., full-time official
health department, as recognized by the Department) having jurisdiction over a
particular area, including city, village, township and county boards of health
and health departments and the responsible executive officers of those boards,
or any person legally authorized to act for the local health authority. In
areas without a health department recognized by the Department, the local
health authority shall be the Department.
"Medical laboratory" – A
facility with a current Clinical Laboratory Improvement Amendments (CLIA)
certificate that receives, forwards, or analyzes specimens of original material
from the human body, or referred cultures of specimens obtained from the human
body, and reports the results to a health care practitioner who uses the data
for purposes of patient care or public health.
"Medical Record" – A
written or electronic account including a patient's medical history, current
illness, diagnosis, details of treatments, chronological progress notes, laboratory
testing, medical imaging tests, and discharge recommendations.
"Monitoring" – The
practice of watching, checking or documenting medical findings of potential
contacts for the development or non-development of an infection or illness.
Monitoring may also include the institution of community-level physical
distancing measures designed to reduce potential exposure and unknowing
transmission of infection to others. Monitoring measures may include, but are
not limited to, reporting of geographic location for a period of time,
restricted use of public transportation, recommended or mandatory mask use,
temperature and/or other symptoms screening prior to entering public buildings
or attending public gatherings.
"Multi-Drug-Resistant
Organisms" or "MDRO" – A pathogen that is resistant to one or
more antimicrobial agents and is usually resistant to all but one or two
commercially available antimicrobial agents.
"Non-Duplicative
Isolate" – The first isolate obtained from any source during each unique
patient/resident encounter, including those obtained for active surveillance or
clinical decision making.
"Novel
Influenza" – An influenza A virus subtype that is different from the
current circulating human influenza A subtypes such as H1 and H3.
"Notifiable disease or
condition" – A disease or condition that, when diagnosed or suspected
based on epidemiological data or test results, requires health providers and
other mandated reporters (usually by law) to report to state or local public
health officials. Notifiable diseases are of public interest by reason of their
contagiousness, severity, or frequency.
"Observation"
− The practice of close medical or other supervision of contacts to
promote prompt recognition of infection or illness.
"Observation and
Monitoring" − Close medical or other supervision, including, but not
limited to, review of current health status, by health care personnel, of a
person or group of persons on a voluntary or involuntary basis to permit prompt
recognition of infection or illness.
"Outbreak"
– The occurrence in a community, facility, workplace or region of a case or
cases of an illness in excess of the number usually expected. The number of
cases indicating an outbreak or cluster will vary according to the agent,
disease, or condition, the site conditions/hazards, size and type of population
exposed, previous experience or lack of exposure to the disease, and time and
place of occurrence.
"Outbreak Reporting
System" or "ORS" – A secure, web-based electronic outbreak
reporting system used by state and local health departments to document and report
outbreaks of disease and health conditions, and to collect a final report
summarizing outbreak outcomes and investigation. Outbreak information
requested by the CDC is uploaded from ORS.
"Point Prevalence Screening"
– A data collection activity tool used to identify the number of persons with a
disease or condition at a specific point in time.
"Premises"
− The physical portion of a building or other structure and its
surrounding area designated by the Director of the Department, his or her
authorized representative, or the local health authority.
"Public
Health Order" − A written or verbal command, directive, instruction
or proclamation issued or delivered by the Department or certified local health
department.
"Public
Transportation" – Any form of transportation that sets fares and is
available for public use, such as taxis; multiple-occupancy car, van or shuttle
services; airplanes; buses; trains; subways; ferries; and boats.
"Quarantine" – The
physical separation and confinement of an individual or groups of individuals
who are or may have been exposed to a contagious disease or possibly contagious
disease and who do not show signs or symptoms. "Quarantine" also
includes the definition of "Quarantine, modified".
"Quarantine, Modified" –
A selective, partial limitation of freedom of movement or actions of a person
or group of persons who are or may have been exposed to a contagious disease or
possibly contagious disease. Modified quarantine is designed to meet
particular situations and includes, but is not limited to, the exclusion of
children from school, the prohibition or restriction from engaging in a
particular occupation or using public or mass transportation, or requirements
for the use of devices or procedures intended to limit disease transmission.
Any travel within Illinois outside of the jurisdiction of the local health
authority must be either approved by the Director or be under mutual agreement
of the health authority of the jurisdiction and the public health official who
will assume responsibility. Travel outside Illinois shall require written
notice from the Illinois jurisdiction to the out-of-state jurisdiction that
will assume responsibility.
"Recombinant
Organism" – A microbe with nucleic acid molecules that have been
synthesized, amplified or modified.
"REDCap" – Research
electronic data capture (REDCap) is a mature, secure web application for
building and managing online surveys and databases. It is used by state and
local health authorities to collect data from persons associated with an
outbreak and can be administered directly to exposed persons via a weblink for
public health surveillance purposes.
"Registry"
– A secure data collection and information system that is designed to support
organized care and improve health outcomes.
"Residential Facility" –
A facility that provides or coordinates custodial care to persons who, because
of physical, mental or emotional disorders, or incarceration, are not able to
live independently.
"Restrict from Work" –
For food handlers, this means to limit the activity of a food handler so that
there is no risk of transmitting a disease by making sure that the food handler
does not work with food, cleaning equipment, clean utensils, clean dishes, clean
linens or unwrapped single service or single use articles or in the preparation
of food.
"School" – An
institution for educating children from Pre-kindergarten to grade 12 supported
either by the state, local government or a private organization or individual.
"Sensitive
Occupation" − An occupation, excluding health care workers,
involving the direct care of others, especially young children and the elderly,
or any other occupation designated by the Department or the local health
authority, including, but not limited to, child care facility personnel.
"Sentinel
Surveillance" – A means of monitoring the prevalence or incidence of
infectious diseases or syndromes through reporting of cases, suspect cases, carriers'
symptoms or submission of clinical materials by selected sites.
"Specimens" – Include,
but are not limited to, blood, sputum, urine, stool, other bodily fluids,
wastes, tissues, and cultures necessary to perform required tests.
"Standard Precautions" –
Infection prevention and control measures that apply to all patients regardless
of diagnosis or presumed infection status (see Section 690.20(a)(7)).
"Sterilization" – The
use of a physical or chemical process to destroy all microbial life, including
large numbers of highly resistant bacterial endospores.
"Susceptible
(non-immune)" − A person who is not known to possess sufficient protection
against a particular pathogenic agent to prevent developing infection or
disease if or when exposed to the agent.
"Syndromic Surveillance"
− Surveillance using health-related data that are collected in near
real-time to detect early changes in illness or injury that may precede final
diagnosis or confirmatory testing and signal a sufficient probability of a
case, event or outbreak to warrant further public health response.
"Tests" – Include, but
are not limited to, any diagnostic or investigative analyses necessary to
prevent the spread of disease or protect the public's health, safety and
welfare.
"Transmission" −
Any mechanism by which an infectious agent is spread from a source or reservoir
to a person, including direct, indirect and airborne transmission.
"Transmission-Based
Precautions" – The second tier of basic infection prevention and control measures
that are to be used in addition to Standard Precautions for patients who may be
infected or colonized with certain infectious agents for which additional
precautions are needed to prevent infection transmission.
"Treatment" – The
provision of health care by one or more health care providers. Treatment
includes any therapeutic interventions, consultation, referral or other
exchanges of information to manage a patient's care.
"Variant Influenza" –
Influenza virus that usually circulates in swine but can cause an influenza
infection in humans.
"Voluntary Compliance" –
Deliberate consented compliance of a person or group of persons that occurs at
the request of the Department or local health authority prior to instituting a
mandatory order for isolation, quarantine, closure, physical examination,
testing, collection of laboratory specimens, observation, monitoring or medical
treatment pursuant to this Subpart.
"Zoonotic Disease" – Any
disease that is transmitted between animals and people.
(Source: Amended at 47 Ill. Reg. 18112,
effective November 22, 2023)
 | TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.20 INCORPORATED AND REFERENCED MATERIALS
Section 690.20 Incorporated and
Referenced Materials
a) The following federal guidelines are incorporated in this
Part:
1) "Updated
CDC Recommendations for the Management of Hepatitis B Virus – Infected
Health-Care Providers and Students", U.S. Department of Health and Human
Services, Public Health Service, Centers for Disease Control and Prevention, 1600
Clifton Rd., Atlanta, GA 30333 (Morbidity and Mortality Weekly Report (MMWR), July
6, 2012, Vol 61, No. RR03, pages 1-12).
2) "Updated
U.S. Public Health Service Guidelines for the Management of Occupational
Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis",
U.S. Department of Health and Human Services, Public Health Service, Centers
for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30333
(Morbidity and Mortality Weekly Report (MMWR), September 30, 2005, Vol. 54, No.
RR-9; pages 1-17).
3) "Prevention
and Control of Meningococcal Disease", Recommendations of the Advisory
Committee on Immunization Practices (ACIP), U.S. Department of Health and Human
Services, Public Health Service, Centers for Disease Control and Prevention, 1600
Clifton Rd., Atlanta, GA 30333 (Morbidity and Mortality Weekly Report (MMWR), March
22, 2013, Vol. 62, No. RR02, pages 1-22).
4) "Investigation
and Control of Vancomycin-Resistant Staphylococcus aureus (VRSA), U.S.
Department of Health and Human Services, Public Health Service, Centers for
Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30333 (April
2015).
5) "2007
Guideline for Isolation Precautions: Preventing Transmission of Infectious
Agents in Healthcare Settings", Jane D. Siegel, MD; Emily Rhinehart, RN
MPH CIC; Marguerite Jackson, PhD; Linda Chiarello, RN MS; the Healthcare
Infection Control Practices Advisory Committee (May 2022), available at:
https://www.cdc.gov/infectioncontrol/pdf/guidelines/isolation-guidelines-H.pdf.
6) "Prevention
of Hepatitis B Virus Infection in the United States: Recommendations of the
Advisory Committee on Immunization Practices", U.S. Department of Health
and Human Services, Public Health Service, Centers for Disease Control and
Prevention, 1600 Clifton Rd., Atlanta, GA 30333 (Morbidity and Mortality
Weekly Report (MMWR), January 12, 2018, Vol. 67, No. RR-1, pages 1-31).
7) "Updated
Norovirus Outbreak Management and Disease Prevention Guidelines", U.S.
Department of Health and Human Services, Public Health Service, Centers for
Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30333 (Morbidity
and Mortality Weekly Report (MMWR), March 4, 2011, Vol. 60, No. RR-3; pages
1-20).
8) "Guideline
for the Prevention and Control of Norovirus Gastroenteritis Outbreaks in
Healthcare Settings, May 2011", U.S. Department of Health and Human
Services, Public Health Service, Centers for Disease Control and Prevention,
1600 Clifton Rd., Atlanta, GA 30333 (May 4, 2011).
9) "General
Best Practice Guidelines for Immunization: Best Practices Guidance", Advisory
Committee on Immunization Practices (ACIP), Kroger A, Bahta L, Long S, Sanchez
P., (February 10, 2023), available at: https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/index.html.
10) "HL7
Version 2.5.1 (or higher) Implementation Guide: Electronic Laboratory Reporting
to Public Health (US Realm) Release 1.5", Health Level Seven
International, 3300 Washtenaw Avenue, Suite 227, Ann Arbor, MI 48104.
11) Promoting
Interoperability: Promoting Interoperability Programs, available at: https//www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms.
12) Infection
Control in Healthcare Personnel: Infrastructure and Routine Practices for
Occupational Infection Prevention and Control Services; Centers for Disease
Control and Prevention, National Center for Emerging and Zoonotic Infectious
Diseases, Division of Healthcare Quality Promotion (October 2019), available
at: https:/www.cdc.gov/infectioncontrol/guidelines/healthcare-personnel/infrastructure.html.
b) The following standards
are incorporated in this Part:
1) "Red
Book: 2021 Report of the Committee on Infectious Diseases, 32nd
ed.", American Academy of Pediatrics, 345 Park Blvd., Itasca, IL 60143.
2) "Prevention
of Hepatitis A Virus Infection in the United States: Recommendations of the
Advisory Committee on Immunization Practices, 2020", available at:
https//www.cdc.gov/mmwr/volumes/69/rr/rr6905a1.htm.
3) "Updated
Recommendations from the Advisory Committee on Immunization Practices (ACIP)
for Use of Hepatitis A Vaccine in Close Contacts of Newly Arriving
International Adoptees", September 18, 2009, MMWR 2009;58(36);1006-1007,
available at: https:www.cdc.gov/mmwr/preview/mmwrhtml/mm5836a4.htm.
c) The following federal
regulations are incorporated in this Part:
1) Privacy
Rule (Standards for Privacy of Individually Identifiable Health Information) of
the Health Insurance Portability and Accountability Act of 1996 (HIPAA) (45 CFR
164.512(a) and (k)(6) (October 1, 2007), 45 CFR 164.506 (October 15, 2002) and
45 CFR 164.501 (October 15, 2002)).
2) Centers
for Medicare and Medicaid Services, Department of Health and Human Services,
Laboratory Requirements (42 CFR 493 (October 1, 2007)).
d) All incorporations by reference of federal regulations and
guidelines and the standards of nationally recognized organizations refer to
the regulations, guidelines and standards on the date specified and do not
include any editions or amendments subsequent to the date specified.
e) The following federal
and State laws and rules are referenced in this Part:
1) Illinois
Statutes
A) Communicable
Disease Report Act [745 ILCS 45]
B) Department
of Public Health Act [20 ILCS 2305]
C) Civil
Administrative Code of Illinois (Department of Public Health Powers and Duties
Law) [20 ILCS 2310]
D) Code of
Civil Procedure [735 ILCS 5]
E) Animal
Control Act [510 ILCS 5]
F) Freedom
of Information Act [5 ILCS 140]
G) Illinois
Emergency Management Act [20 ILCS 3305]
H) Medical
Studies Act [735 ILCS 5/8-2101]
I) Illinois
Health Statistics Act [410 ILCS 520]
2) Illinois
Rules
A) Control
of Sexually Transmissible Infections Code (77 Ill. Adm. Code 693)
B) Illinois
Clinical Laboratories Code (77 Ill. Adm. Code 450)
C) Certified
Local Health Department Code (77 Ill. Adm. Code 600)
D) Child and
Student Health and Immunization Examination Code (77 Ill. Adm. Code 665)
E) College
Immunization Code (77 Ill. Adm. Code 694)
F) Control
of Tuberculosis Code (77 Ill. Adm. Code 696)
G) HIV/AIDS
Confidentiality and Testing Code (77 Ill. Adm. Code 697)
H) Perinatal
HIV Prevention Code (77 Ill. Adm. Code 699)
I) Health
and Hazardous Substances Registry Code (77 Ill. Adm. Code 840)
J) Health
Care Data Collection and Submission Code (77 Ill. Adm. Code 1010)
3) Federal Statutes
A) Health
Insurance Portability and Accountability Act of 1996 (HIPAA) (42 U.S.C. 1320d-2)
B) Clinical
Laboratory Improvement Amendments of 1988 (CLIA) (42 U.S.C. 263a)
C) Homeland
Security Act of 2002 (6 U.S.C. 101)
(Source: Amended at 47 Ill.
Reg. 18112, effective November 22, 2023)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.30 GENERAL PROCEDURES FOR THE CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS, INCLUDING OUTBREAKS
Section 690.30 General
Procedures for the Control of Notifiable Diseases and Conditions, Including
Outbreaks
This Section establishes routine
measures for the control of notifiable diseases, conditions and outbreaks by
the Department or local health authorities and health care providers, and
establishes progressive initiatives to ensure that appropriate measures are
implemented to control the spread and occurrence of notifiable diseases, conditions
and outbreaks. This Section does not apply to infectious or non-infectious
diseases and conditions for which reporting requirements are specified
elsewhere in the Illinois Administrative Code, such as sexually transmissible
infections, which are regulated under the Control of Sexually Transmissible
Infections Code, the HIV/AIDS Confidentiality and Testing Code, and the
Perinatal HIV Prevention Code.
a) Investigation
1) The
Department of Public Health shall investigate the causes of contagious, or
dangerously contagious, or infectious diseases, especially when existing
in epidemic form, and take means to restrict and suppress the same, and
whenever such disease becomes, or threatens to become, epidemic in any locality
and the local board of health or local authorities neglect or refuse to enforce
efficient measures for its restriction or suppression or to act with sufficient
promptness or efficiency, or whenever the local board of health or local
authorities neglect or refuse to promptly enforce efficient measures for the restriction
or suppression of dangerously contagious or infectious diseases, the Department
of Public Health may enforce such measures as it deems necessary to protect the
public health, and all necessary expenses so incurred shall be paid by the
locality for which services are rendered. (Section 2(a) of the Act)
2) The
Department shall make investigations and inquiries with respect to the
causes of disease, health conditions, and death; investigate the effect
of environment, including conditions of employment and other conditions that
may affect health; and to make other investigations that it may deem necessary
for the preservation and improvement of health. (Section 510 of the Public
Health Powers and Duties Law)
3) Each case or cluster of a notifiable disease or condition shall
be investigated to determine the source, where feasible. Findings of the
investigation shall be reported as specified under the Section of this Part
applicable to each specific disease.
4) The
Department or local health authority may investigate the occurrence of cases, suspect
cases, or carriers of diseases or conditions or unusual disease or condition occurrences
in a public or private place for the purposes of verifying the existence of a disease
or condition; ascertaining the source of the disease or condition-causing
agent; identifying unreported cases; locating and evaluating contacts of cases
and suspect cases; identifying those at risk of disease or the condition;
determining necessary control measures, including isolation and quarantine; and
informing the public if necessary.
5) When
the Director determines that a certain disease or condition warrants investigation,
the Director may declare the disease or condition to be the subject of a
medical investigation and require hospitals, physicians, health care facilities,
etc., to submit information, data and reports, and allow review and examination
of medical records as necessary for the purpose of the investigation. No
practitioner or person shall be liable in any action at law for permitting
examination and review. The data obtained shall be held confidential in
accordance with the Communicable Disease Report Act.
6) When two
or more cases of a suspected or notifiable disease or condition, including, but
not limited to confirmed health care associated infection or colonization, or
single case with public health significance occur in any business,
organization, institution, health care facility, school, child care center or provider,
residential facility, or private home, the business owner, the person in charge
of the establishment or the event, or the homeowner shall cooperate with public
health authorities in the investigation of cases, suspect cases, outbreaks and
suspect outbreaks. This includes, but is not limited to, release of utilization
information about a product used to mitigate spread, including therapeutics;
shopper card records; credit card receipts; food preparation methods; menus; environmental
specimens; food specimens; clinical specimens, invoices, employee work
schedules and work logs, including logs of employee illness or absences; lists
of customers, attendees, residents or patients; travel/transportation logs; utilization
information about a product used to mitigate spread, including therapeutics,
vaccinations or prophylactics; and the name and other pertinent information
about employees, guests, members or residents diagnosed with a communicable
disease or condition, including infection or colonization as the information
relates to the investigation. When outbreaks of infectious disease occur in any
business, organization, institution, health care facility or private home,
employees of the location under investigation may be considered to be contacts
to cases and be required to submit release specimens by the local health
authority.
7) When two or more cases of a notifiable communicable disease or
condition occur in association with a common source, the investigation should
include a search for additional cases.
8) All reports of an outbreak shall be
entered in the Department’s ORS by the local health jurisdiction within 24
hours of receipt of the report. Within 30 days of the end of the outbreak
investigation, the final information shall be entered in the Department’s ORS.
Supplemental questionnaires may be used during the outbreak investigation,
including, but not limited to use of REDCap or other online systems.
9) Under circumstances with highly infectious diseases or other
disease or conditions causing extreme harm, including, but not limited to, high
risk or high occurrence of death or complication, and when normal attempts to
make contact have failed, the Department, local health authority, or law
enforcement may obtain and review any cell phone, computer, mobile device or
other communication device, from a case for the purpose of the investigation,
including, but not limited to, the identification of possible contacts or
possible exposures, for the purpose of preventing or controlling disease or the
condition.
10) State and local law enforcement authority shall share
information with the Department or local health department as requested by
either the Department or the local health authority for the treatment, response
to, control of, investigation of, or prevention of a notifiable disease,
condition or outbreak.
11) The
Department or local health authority may conduct sentinel surveillance for an infectious
disease, condition or syndrome if the Department or local health authority determines
that sentinel surveillance will provide adequate data for the purpose of
preventing or controlling disease or the condition or achieving other
significant public health purposes in a defined geographic area or the entire
State. The Department or local health authority shall select, after
consultation with the sites, sentinel surveillance sites that have
epidemiological significance for the disease, condition or syndrome under
investigation. A disease, condition or syndrome may be removed from sentinel
surveillance if the Department or local health authority determines that the
surveillance is no longer necessary. The Department or local health authority shall
provide a description, in writing, to sentinel surveillance sites of a
specific, planned mechanism for surveillance of the disease, condition or
syndrome and, as necessary, submission of clinical materials from cases and
suspect cases.
12) An individual or entity, including a health information
exchange, may carry out activities such as sentinel surveillance under a grant,
contract or cooperative agreement with the Department. The authorized
individual or entity functions as a public health authority for the purposes of
the activity.
13) Investigations
conducted by the Department or local health authority may include, but are not
limited to:
A) Review
of pertinent, relevant medical records by authorized personnel, if necessary to
confirm the diagnosis; investigation of causes; identification of other cases
related to the outbreak or the reported disease (including colonization) or
condition in a region, community, or workplace; to conduct epidemiologic
studies; to determine whether a patient with a notifiable disease or condition has
received adequate treatment to render the patient non-infectious, whether a
person exposed to a case has received vaccination or prophylaxis, if
appropriate, or infection or environmental control measures have been
implemented, if appropriate. Review of records may occur without patient
consent and shall be conducted at times and with such notice as is possible
under the circumstances;
B) Performing
interviews with the case, or persons knowledgeable about the case, and
collecting pertinent and relevant information about the causes of or risk
factors for the notifiable disease or condition;
C) Medical
examination and testing of persons, with their explicit consent;
D) Obtaining,
from public or private businesses or institutions, the identities of and location
and contact information about persons, travelers, passengers or transportation
crews with a similar or common potential exposure to the infectious agent as a
reported case; exposure may be current or have occurred in the past;
E) Interviewing
or administering questionnaire surveys confidentially to any resident of any
community, or any agent, owner, operator, employer, employee, or client of a
public or private business or institution, who is epidemiologically associated
either with the outbreak or with the reported disease or condition case or has
had a similar exposure as a reported case;
F) Collecting
environmental samples of substances or measurements of physical agents that may
be related to the cause of an outbreak or notifiable disease or condition;
G) Taking
photographs related to the purpose of the investigation. If the photographs are
taken in a business, the employer shall have the opportunity to review the
photographs taken or obtained for the purpose of identifying those that contain
or might reveal a trade secret; and
H) Entering
a place of employment for the purpose of conducting investigations of those
processes, conditions, structures, machines, apparatus, devices, equipment,
records, and materials within the place of employment that are relevant,
pertinent, and necessary to the investigation of the outbreak or notifiable
dangerously contagious or infectious disease. Investigations shall be
conducted during regular business hours, if possible, and with as much notice
as possible under the circumstances.
b) Control of Food Products
Whenever a
case, a carrier, or a suspect case or carrier of the following diseases exists
in a home or establishment where food is produced that is likely to be consumed
raw or handled after pasteurization and before final packaging, the sale,
exchange, removal or distribution of the food items from the home or establishment
may be prohibited by the Department or the local health authority as necessary
to prevent the transmission of communicable diseases or conditions. These
include, but are not limited to, the following diseases:
1) Campylobacteriosis
2) Cholera
3) Cryptosporidiosis
4) Diphtheria
5) E. coli infections (Shiga toxin-producing E. coli)
6) Foodborne or waterborne illness
7) Hepatitis A
8) Norovirus
9) Salmonellosis
10) Shigellosis
11) Smallpox
12) Staphylococcal skin infections
13) Streptococcal infections
14) Typhoid fever
c) Schools, Child Care Facilities, and Colleges/Universities
1) Except in an emergency, the occurrence of a case of a
communicable disease in a school, child care facility or college/university
should not be considered a reason for closing the school, facility or
college/university.
2) Persons suspected of being infected with a notifiable
infectious disease for which isolation is required, or persons with diarrhea or
vomiting believed to be infectious in nature, shall be refused admittance to
the school or child care facility until fever-free and diarrhea and vomiting
free for 24 hours without use of fever reducing, antidiarrheal, or antiemetic medications
and other medications.
3) School, child care facility, and college/university
authorities shall handle contacts of infectious disease cases as prescribed in
this Part, or as recommended by the local health authority.
4) When outbreaks of disease occur in any child care facility,
staff and attendees of the facility may be considered to be contacts to cases
and may be required by the local health authority to submit specimens for
testing.
5) Identifiable information on a student or staff, such as name
and contact information (including current address and phone), seating charts
on busses and in the classroom, and rosters for extracurricular activities,
shall be reported to the Department or local public health authority for any
notifiable disease or condition within the timeframes specified in this Part.
d) Release of Specimens
1) Whenever this Part requires the submission of laboratory
specimens for release from imposed restrictions, the results of the
examinations will not be accepted unless the specimens have been examined in
the Department's laboratory or an acceptable medical laboratory. The number of
specimens needed for release, as detailed under specific diseases, is the
minimum and may be increased by the Department as necessary. Improper storage
or transportation of a specimen or inadequate growth of the culture suggestive
of recent antibiotic usage can result in disapproval of the submitted specimen
by the Department's laboratory or an acceptable medical laboratory and result
in the need for an additional specimen to be collected.
2) The
local health authority may require testing of food handlers for specific
pathogens, including, but not limited to, E. coli, Salmonella and Norovirus, as
necessary in response to an outbreak.
3) A
local health authority may disclose and require to a food service business
owner or the owner’s designee that an employee with a disease that can be
transmitted through food cannot return to work until the local health authority
lets the business owner know that the employee can return to work.
e) Persons
with diarrhea or vomiting of infectious or unknown cause shall not work in
sensitive occupations, as a health care worker, or as food handlers until 48
hours after diarrhea and vomiting have resolved without use of antidiarrheal or
antiemetic medications and shall adhere to restrictions specified in this Part
specific to each etiologic agent.
f) Persons with draining skin lesions shall not
work as food handlers unless the drainage is contained by a dressing and
lesions are not on the hands or forearms.
g) Persons with jaundice and the onset of jaundice within seven
calendar days shall not work as health care workers, food handlers or in
sensitive occupations until seven days after the jaundice ceases, unless the
employee provides written documentation from a health care provider that the jaundice
is not caused by the hepatitis A virus or other fecal-orally transmitted
infection. If the case is confirmed as hepatitis A and jaundice is not
present, the health care worker, food handler or person in a sensitive
occupation shall be restricted from work for two weeks from the start of the
clinical symptoms.
(Source: Amended at 47 Ill.
Reg. 18112, effective November 22, 2023)
SUBPART B: NOTIFIABLE DISEASES AND CONDITIONS
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.100 DISEASES AND CONDITIONS
Section 690.100 Diseases and
Conditions
The following notifiable
diseases and conditions are declared to be infectious or communicable or of
public health significance. Each suspected or diagnosed case shall be reported
to the local health authority, which shall subsequently report each case to the
Department. The method of reporting shall be as described in the individual
Section for the disease or condition. Appropriate infection control standards
shall be implemented for cases and contacts per existing infection prevention
and control standard precautions and transmission-based protocols.
a) Class I(a)
The following diseases or
conditions shall be reported immediately (within three hours) by telephone,
upon initial clinical suspicion of the disease or condition, to the local
health authority, which shall then report to the Department immediately (within
three hours). This interval applies to primary reporters identified in Section
690.200(a)(1) who are required to report to local health authorities and to
local health authorities that are required to report to the Department. The
Section number associated with each of the listed diseases or conditions indicates
the Section under which the diseases or conditions are reportable. Laboratory
specimens of agents required to be submitted under Subpart D shall be submitted
within 24 hours to the Department laboratory.
|
1)
|
Any unusual case of a disease
or condition not listed in this Part that is of urgent public health
significance
|
690.295
|
|
|
|
|
|
2)
|
Anthrax*
|
690.320
|
|
|
|
|
|
3)
|
Botulism, foodborne
|
690.327
|
|
|
|
|
|
4)
|
Brucellosis* (if suspected to
be a bioterrorist event or part of an outbreak)
|
690.330
|
|
|
|
|
|
5)
|
Coronavirus, Novel, including
Severe Acute Respiratory Syndrome (SARS) and Middle Eastern Respiratory
Syndrome (MERS)
|
690.361
|
|
|
|
|
|
6)
|
Diphtheria*
|
690.380
|
|
|
|
|
|
7)
|
Influenza A, Novel or Variant Virus*
|
690.469
|
|
|
|
|
|
8)
|
Measles, suspect, probable or
confirmed*
|
690.520
|
|
|
|
|
|
9)
|
Plague*
|
690.570
|
|
|
|
|
|
10)
|
Poliomyelitis
|
890.580
|
|
|
|
|
|
11)
|
Q-fever* (if suspected to be a
bioterrorist event or part of an outbreak)
|
690.595
|
|
|
|
|
|
12)
|
Smallpox
|
690.650
|
|
|
|
|
|
13)
|
Tularemia*
(if suspected to be a bioterrorist event or part of
an outbreak)
|
690.725
|
|
|
|
|
|
14)
|
Any
suspected bioterrorist threat or event
|
690.800
|
b) Class I(b)
The following
notifiable diseases or conditions shall be reported as soon as possible during
normal business hours, but within 24 hours (i.e., within eight regularly
scheduled business hours after identifying the case), to the local health
authority, which shall then report to the Department as soon as possible, but
within 24 hours. This interval applies to primary reporters identified in
Section 690.200(a)(1) who are required to report to local health authorities
and to local health authorities that are required to report to the Department.
The Section number associated with each of the listed diseases and conditions indicates
the Section under which the diseases and conditions are reportable. Laboratory
specimens of agents required to be submitted under Subpart D shall be submitted
within three days after identification of the organism to the Department
laboratory.
|
1)
|
Acute Flaccid Myelitis (AFM)
|
690.290
|
|
|
|
|
|
2)
|
Botulism, intestinal, wound,
and other
|
690.327
|
|
|
|
|
|
3)
|
Brucellosis* (if not suspected to be a bioterrorist event
or part of an outbreak)
|
690.330
|
|
|
|
|
|
4)
|
Chickenpox (Varicella)
|
690.350
|
|
|
|
|
|
5)
|
Cholera*
|
690.360
|
|
|
|
|
|
6)
|
Cronobacter, including C.
sakazakii and C. malonaticus, in infants younger than 12 months of
age
|
690.362
|
|
|
|
|
|
7)
|
Escherichia coli infections*
(E. coli O157:H7 and other Shiga toxin-producing E. coli)
|
690.400
|
|
|
|
|
|
8)
|
Haemophilus influenzae,
invasive disease*
|
690.441
|
|
|
|
|
|
9)
|
Hantavirus pulmonary syndrome*
|
690.442
|
|
|
|
|
|
10)
|
Hemolytic uremic syndrome, post-diarrheal
|
690.444
|
|
|
|
|
|
11)
|
Hepatitis A
|
690.450
|
|
|
|
|
|
12)
|
Melioidosis due to Burkholderia
pseudomallei
|
690.530
|
|
|
|
|
|
13)
|
Mumps
|
690.520
|
|
|
|
|
|
14)
|
Neisseria meningitidis, invasive
disease and purpura fulminans *
|
690.555
|
|
|
|
|
|
15)
|
Any Suspected or Confirmed
Outbreak of a Disease of Known or Unknown Etiology that may be a Danger to
the Public Health, Whether the Disease, Infection, Microorganism, or
Condition is specified in the Rule (including, but not limited to, foodborne,
healthcare-associated, zoonotic disease, and waterborne outbreaks)
|
690.565
|
|
|
|
|
|
16)
|
Pertussis (whooping cough)
|
690.750
|
|
|
|
|
|
17)
|
Q-fever due to Coxiella
burnetii* (if not suspected to be a bioterrorist event or part of an
outbreak)
|
690.595
|
|
|
|
|
|
18)
|
Rabies, human
|
690.600
|
|
|
|
|
|
19)
|
Rabies, potential human
exposure and animal rabies
|
690.601
|
|
|
|
|
|
20)
|
Rubella
|
690.620
|
|
|
|
|
|
21)
|
SARS-CoV-2 Infection (COVID-19)
(Laboratory Confirmed Testing via ELR only, Pediatric Deaths, and Intensive
Care Unit Admissions)
|
690.635
|
|
|
|
|
|
22)
|
Staphylococcus aureus
infections with intermediate or high level resistance to Vancomycin*
|
690.661
|
|
|
|
|
|
23)
|
Tularemia* (if not suspected to be a bioterrorist event
or part of an outbreak)
|
690.725
|
|
|
|
|
|
24)
|
Typhoid fever* and Paratyphoid
fever (including S. Typhi, S. Paratyphi A, S. Paratyphi B (tartrate negative)
and S. Paratyphi C cases)
|
690.730
|
|
|
|
|
|
25)
|
Typhus
|
690.740
|
c) Class II
The following
notifiable diseases and conditions shall be reported as soon as possible during
normal business hours, but within three days, to the local health authority,
which shall then report to the Department as soon as possible during normal
business hours but within three additional days. The Section number associated
with each of the listed diseases and conditions indicates the Section under
which the diseases are reportable. Laboratory specimens of agents required to
be submitted under Subpart D shall be submitted within three days after
identification of the organism to the Department laboratory.
|
1)
|
Arboviral Infection*
|
690.322
|
|
|
|
|
|
2)
|
Campylobacteriosis
|
690.335
|
|
|
|
|
|
3)
|
Cryptosporidiosis
|
690.365
|
|
|
|
|
|
4)
|
Cyclosporiasis
|
690.368
|
|
|
|
|
|
5)
|
Hepatitis B
|
690.451
|
|
|
|
|
|
6)
|
Hepatitis C
|
690.452
|
|
|
|
|
|
7)
|
Histoplasmosis
|
690.460
|
|
|
|
|
|
8)
|
Influenza (Laboratory
Confirmed Deaths in persons younger than 18 years of age)
|
690.465
|
|
|
|
|
|
9)
|
Influenza (Laboratory
Confirmed Testing via ELR only and Intensive Care Unit Admissions)
|
690.468
|
|
|
|
|
|
10)
|
Legionellosis*
|
690.475
|
|
|
|
|
|
11)
|
Leptospirosis*
|
690.490
|
|
|
|
|
|
12)
|
Listeriosis*
|
690.495
|
|
|
|
|
|
13)
|
Malaria*
|
690.510
|
|
|
|
|
|
14)
|
Multi-drug resistant organisms
considered to be of epidemiologic importance due to either severity of
clinical disease, potential for transmission of genetic elements, or
opportunities for effective control efforts
|
690.445
|
|
|
|
|
|
15)
|
Psittacosis due to Chlamydia
psittaci
|
690.590
|
|
|
|
|
|
16)
|
Respiratory Syncytial Virus
(RSV) Infection (Laboratory Confirmed Testing via ELR only, Pediatric Deaths,
and Intensive Care Unit Admissions)
|
690.605
|
|
|
|
|
|
17)
|
Salmonellosis* including
Paratyphi V var. L(+) tartrate+ (other than S. Typhi, S. Paratyphi A., S
Paratyphi B (tartrate negative) and S. Paratyphi C cases)
|
690.630
|
|
|
|
|
|
18)
|
SARS-CoV-2 Infection
(COVID-19) (Laboratory Confirmed Testing via ELR only, Pediatric Deaths, and
Intensive Care Unit Admissions)
|
690.635
|
|
|
|
|
|
19)
|
Shigellosis*
|
690.640
|
|
|
|
|
|
20)
|
Streptococcal infections,
Group A, invasive and sequelae to Group A streptococcal infections In Persons
Admitted to the Hospital or Residing in a Residential Facility, including
antibiotic susceptibility test results
|
690.670
|
|
|
|
|
|
21)
|
Toxic shock syndrome due to
Staphylococcus aureus infection
|
690.695
|
|
|
|
|
|
22)
|
Streptococcus pneumoniae,
invasive disease in children younger than five years
|
690.678
|
|
|
|
|
|
23)
|
Tetanus
|
690.690
|
|
|
|
|
|
24)
|
Tickborne Infections,
including African Tick Bite Virus, Anaplasmosis, Babesiosis, Bourbon Virus, Ehrlichiosis,
Heartland Virus, Lyme disease, and Spotted Fever Rickettsiosis
|
690.698
|
|
|
|
|
|
25)
|
Trichinosis
|
690.710
|
|
|
|
|
|
26)
|
Vibriosis (Other than
Toxigenic Vibrio cholera O1 or O139)*
|
690.745
|
* Diseases or
conditions for which laboratories are required to forward clinical materials to
the Department's laboratory in accordance with Subpart D of this Part.
d) When an epidemic of a disease or conditions dangerous to the
public health occurs, and present rules are not adequate for its control or
prevention, the Department shall issue more stringent requirements.
(Source: Amended at 48 Ill.
Reg. 15900, effective October 23, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.110 DISEASES AND CONDITIONS PREVIOUSLY RENUMBERED OR REPEALED FROM SECTIONS OF THIS PART AND WHICH DISEASES AND CONDITIONS REMAIN REPORTABLE TO THE DEPARTMENT UNDER OTHER PARTS AND SECTIONS
Section 690.110 Diseases and
Conditions Previously Renumbered or Repealed from Sections of This Part and
Which Diseases and Conditions Remain Reportable to the Department Under Other
Parts and Sections
a) The following diseases and conditions have been repealed from
this Part and are no longer reportable.
1) Amebiasis
2) Blastomycosis
3) Creutzfeldt
Jakob Disease (CJD)
4) Diarrhea
of the newborn
5) Giardiasis
6) Hepatitis,
viral, other
7) Leprosy
(Hansen's Disease)
8) Meningitis,
aseptic
9) Staphylococcus
aureus, Methicillin Resistant (MRSA) Infection, clusters of two or more laboratory
confirmed cases occurring in community settings
10) Staphylococcus
aureus, Methicillin Resistant (MRSA), any occurrence in an infant younger than
61 days of age
11) Streptococcal
infections, group B, invasive disease, of the newborn
12) Yersiniosis
b) The
following diseases have been previously renumbered or repealed from this Part,
but are reportable under the Parts and Sections specified:
|
1)
|
Acquired immunodeficiency
syndrome (AIDS)
|
77 Ill. Adm.
Code 693.20
|
|
|
|
|
|
2)
|
Chancroid
|
77 Ill. Adm.
Code 693.20
|
|
|
|
|
|
3)
|
Gonorrhea
|
77 Ill. Adm.
Code 693.20
|
|
|
|
|
|
4)
|
Severe Acute Respiratory
Syndrome (SARS)
|
77 Ill. Adm.
Code 690.361
|
|
|
|
|
|
5)
|
Syphilis
|
77 Ill. Adm.
Code 693.20
|
|
|
|
|
|
6)
|
Tuberculosis
|
77 Ill. Adm.
Code 696.170
|
(Source: Amended at 47 Ill. Reg. 18112,
effective November 22, 2023)
SUBPART C: REPORTING
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.200 REPORTING
Section 690.200 Reporting
a) Reporting Entities and Manner of Reporting
1) Each of the following persons or any other person having
knowledge of a known or suspect case or carrier of a disease or condition or
death from a notifiable disease or condition shall report the case, suspect
case, carrier or death in humans within the time frames set forth in Section
690.100:
A) Physicians
B) Physician
assistants
C) Nurses
and advanced practice nurses
D) Nursing
assistants
E) Dentists
F) Health
care practitioners
G) Emergency
medical services personnel
H) Infection
Preventionists
I) Laboratory
personnel
J) Long-term
care personnel
K) Any
institution, school, college/university, child care facility or camp personnel
L) Pharmacists
and pharmacy technicians
M) Poison control center
personnel
N) Blood
bank and organ transplant personnel
O) Coroners,
funeral directors, morticians and embalmers
P) Medical
examiners
Q) Veterinarians
R) Correctional facility
personnel
S) Food service management
personnel
T) The
master, pilot or any other person in charge of any bus, train, ship or boat,
and the commander, pilot or any other person in charge of any aircraft within
the jurisdiction of the State
U) Researchers
V) Animal control or animal shelter employees
W) Any
other person having knowledge of a known or suspected case or carrier of a notifiable
disease or condition or disease or condition-related death.
2) An individual required to report notifiable diseases or
conditions who is unsure whether the case meets the definition of a suspect
case shall make a report if the suspect disease, infection or condition is one
that is required to be reported immediately, is highly transmissible, or could
result in health consequences to others.
3) A
health care provider who attends to a case, carrier or suspect case shall
inform the case, carrier or suspect case and the case's, carrier's or suspect
case's contacts of the applicable requirements of isolation, exclusion,
quarantine, screening, treatment or prophylactic measures and other precautions
necessary to prevent the spread of disease.
4) Laboratories shall report certain positive test results and
provide clinical materials as specified in Subpart D or if requested. Upon
request of the local health authority, laboratories shall submit a copy of a
laboratory report by facsimile or electronically. If
a medical laboratory forwards clinical materials out of the State for testing,
the originating medical laboratory shall comply with this requirement by either
reporting the results and submitting clinical materials to the Department or
ensuring that the results are reported and materials are submitted to the
Department. Laboratories shall report negative or indeterminate test
results as requested by the Department, when necessary for the investigation,
monitoring, control and prevention of diseases dangerous to the public health.
5) The reports shall be submitted electronically through the
Electronic Disease Surveillance System (EDSS) web-based system or by mail,
telephone, facsimile, other secure electronic system integrated with EDSS, or
other Department designated registry to the local health authority in whose
jurisdiction the reporter is located.
A) The method of reporting shall be as described in the individual
Section for the notifiable disease or condition.
B) Laboratories shall submit data electronically through EDSS in
accordance with HL7 Version 2.5.1 (or higher) Implementation Guide: Electronic
Laboratory Reporting to Public Health, Release 1 and with Logical Observation
Identifiers Names and Codes (LOINC) and Systematized Nomenclature of Medicine
(SNOMED) codes to specify testing information and results, respectively.
Laboratories can request an exemption based on small case volumes, and the
Department will evaluate the request against past testing volumes. Prior to
establishing electronic reporting, laboratories shall report via browser-based
data entry into EDSS.
C) Providers shall establish a data linkage and submit electronic
case report data through the Association of Public Health Laboratories
Informatics Messaging Service (AIMS) platform in accordance with CMS Promoting
Interoperability standards.
D) The Department will electronically route these reports to the
local health authority in whose jurisdiction the patient is located. If this
information is not available, then the record will be routed to the
jurisdiction of the ordering provider. The Department will prescribe the use of
a health information exchange to achieve these purposes when a health
information exchange is available.
E) The reporter shall provide, when available, disease or
condition, name, age, date of birth, sex, race, ethnicity, address (including
zip code), email address and telephone number (if available) of the case, and
name and telephone number of the attending medical provider. When requested, on
paper forms provided by the Department or electronically through EDSS or AIMS,
clinical and laboratory findings in support of the diagnosis, epidemiological
facts relevant to the source of the infection or condition, and possible hazard
of transmission of the infection or condition shall also be reported.
F) A laboratory or provider that is required to report data
electronically shall have a State-approved continuity of operations plan for
reporting continuity in emergency situations that disrupt electronic
communications. At least two alternative methodologies shall be incorporated,
such as facsimile, mail or courier services.
6) During an outbreak investigation, the reporter and any
involved business, organization or institution shall cooperate in any case
investigation conducted by health officials, which includes, but is not limited
to, supplying location and contact information for those individuals believed
to be associated with the outbreak.
7) Any party receiving the reports shall notify the local health
authority where the patient resides immediately by phone (within three hours)
for Class I(a) diseases and conditions, within 24 hours (during normal business
hours) for Class I(b) diseases and conditions and within three days for Class
II diseases or conditions. When a case of a notifiable disease or condition is
reported from one local health authority's jurisdiction but resides in
another's jurisdiction, the case shall be transferred electronically in EDSS
with additional relevant information supplied to the other jurisdiction. If a
known or suspect case or carrier of a notifiable disease or condition is
hospitalized or examined in a hospital or long-term care facility, the
administrator of the health care facility shall ensure that the case is
promptly reported to the local health authority within the time frame specified
in Section 690.100 for that disease.
8) Veterinarians, animal control officials, animal holding
facility personnel, retail stores selling animals and wildlife professionals
shall report any zoonotic disease outbreak in persons including location and contact
information for the owner of the animals suspected of causing the outbreak, as
well as any new or emerging zoonotic disease illness in a single person or any
human contacts to the infected animals.
b) Upon receipt of this report, the local health authority shall
report cases to the Department as specified in this Section. Local health
authorities shall report cases to the Department using EDSS according to the
time frames specified in Section 690.100. The processing of electronic
laboratory reports in EDSS or via AIMS is equivalent to reporting a case to the
Department. If EDSS becomes temporarily non-functional, the local health
authority may report to the Department by secure email, mail, telephone or
facsimile.
c) The report to the Department and local health authority shall
provide the following information: disease or condition, name, age, date of
birth, sex, race, ethnicity, address (including zip code), email address and
telephone number (if available) of the case, and telephone number and name of
the attending physician. When requested, on paper forms provided by the
Department or electronically through the EDSS, clinical and laboratory findings
in support of the diagnosis, epidemiological facts relevant to the source of
the infection, and possible hazard of transmission of the infection shall also
be reported. In some instances where no specific report form is available, a
narrative report detailing diagnostic and epidemiologic information shall be
required.
d) Confidentiality
1) The
Department will maintain the confidentiality of information that would identify
individual patients, including, but not limited to, the identity or any group
of facts that tends to lead to the identity of any facility or of any person
whose condition or treatment is submitted to the Department or local health
authority. The following data elements, alone or in combination, may be
considered confidential: name, sex, social security number, address (including
street, city and county), email address, telephone number, facsimile number,
dates (other than year) directly related to an individual, medical record
number, health insurance beneficiary numbers, certificate or license number,
reporting source (unless permitted by the reporting facility), age (unless aggregated
for five or more years), age greater than 89, and zip code (unless aggregated
for five or more years). Data defined by geographic area that are smaller than
zip code, such as census tract or census block groups, may be considered
confidential.
2) The Department and local health authority will maintain the
confidentiality of recipes, and vendor and distributor information collected as
part of an outbreak or illness investigation. The Department or local health
authority will share such information with public health partners as necessary
for the purposes of an outbreak or illness investigation.
3) Epidemiologic information (including,
but not limited to epidemiologic line listings), documents and correspondence
between the Department, local health authority, the CDC and other state and
federal agencies is considered confidential. The Department will share such
information with public health partners as necessary for the purposes of an
outbreak or illness investigation.
4) Whenever any medical practitioner or other person is required
by statute, regulation, ordinance or resolution to report cases of notifiable
diseases or conditions to any government agency or officer, the reports shall
be confidential. Any medical practitioner or other person who provides a
report of a disease or condition in good faith shall have immunity from suit
for slander or libel for statements made in the report. The identity of any
individual contained in a report of a notifiable disease or condition or an
investigation conducted pursuant to a report of a disease or condition shall be
confidential, and the individual's identity shall not be disclosed publicly in
an action of any kind in any court or before any tribunal, board or agency.
The individual, his/her legal guardian or his/her estate, with proper consent,
may have his/her information released as requested.
5) As
outlined in the Privacy Rule (Standards for Privacy of Individually
Identifiable Health Information) of the Health Insurance Portability and
Accountability Act of 1996 (HIPAA), health information may be disclosed to
public health authorities when required by federal, tribal, state, or local
laws. This includes the requirements set forth in this Part that provide for
reporting a disease or condition or conducting public health surveillance,
investigation, or intervention. For disclosures not required by law, a public
health authority may collect or receive information for the purpose of
preventing or controlling disease or a condition.
6) To prevent
the spread of a disease or condition, the Department, local boards of health,
and local health authorities may share confidential
health information contained in surveillance reports and other
individually identifiable health information with each other. In addition, the
Department and local health authorities may share
confidential health information contained in surveillance reports and
other individually identifiable health information with health care facilities
and health care providers, to the extent necessary for treatment, prevention or
control of a disease or condition. The Department will share the information in
a secure manner that protects the confidentiality of the protected health
information.
7) Subsections
(d)(1) through (5) shall not prevent the Director or authorized personnel of
the Department from furnishing what the Department determines to be appropriate
information to a physician or institution providing examination or treatment to
a person suspected of or affected with a disease or condition, including
carrier status, of public health interest, or to any person or institution when
necessary for the protection of public health. Only the minimum information
necessary for the intended purpose shall be disclosed. A person or institution
to whom information is furnished or to whom access to records has been given
shall not divulge any part of the information so as to disclose the identity of
the person to whom the information or record relates, except as necessary for
the treatment of a case or carrier or for the protection of the health of
others.
8) To
prevent the spread of a disease or condition, the Department, local boards of
health, local health authorities, and other state agencies involved with direct
care and service provisions to individuals shall have emergency access to
medical or health information or records or data upon the condition that the
Department, local boards of health, and local health authorities protect the
privacy and confidentiality of any medical or health information or records or
data obtained pursuant to Section 2 of the Department of Public Health Act, in
accordance with federal and State law. Any medical or health information or
records or data shall be exempt from inspection and copying under the Freedom
of Information Act. Any person, facility, institution, or agency that provides
emergency access to health information and data shall have immunity from any
civil or criminal liability, or any other type of liability that might result,
except in the event of willful and wanton misconduct. The privileged quality of
communication between any professional person or any facility shall not
constitute grounds for failure to provide emergency access.
9) The
Department will provide information pertaining to human or animal cases of
zoonotic disease to another State or federal agency, including but not limited
to the Centers for Disease Control and Prevention, Federal Drug Administration
and U.S. Department of Agriculture, Illinois Department of Agriculture, and
Illinois Department of Natural Resources only if the disease is reportable to
the agency or if another agency is assisting with control of an outbreak.
10) Information
contained in EDSS and other Department registries shall be confidential and not
subject to inspection by persons other than authorized personnel or agents of
the Department, certified local health authorities, and other authorized
persons or agencies authorized in this Part.
A) In
accordance with the Health Insurance Portability and Accountability Act
(HIPAA) Privacy Rule permitting a health care provider to disclose protected
health information about an individual, without the individual's authorization,
to another health care provider for that provider's health care treatment of
the individual (see HIPAA 45 CFR 164.506 and the definition of "treatment"
at HIPAA 45 CFR 164.501), the Department may disclose information contained in EDSS
and other Department registries, and the Department may permit access to the
information by a licensed health care worker or health care institution that is
treating or testing the individual to whom the information relates for the protection
of the individual's health or the public's health, including prevention
purposes.
B) The
Department may also disclose what it considers to be appropriate and necessary
information from EDSS and other Department registries to a licensed health care
provider or health care institution or congregate living facility when:
i) the
licensed health care provider or health care institution or congregate living
facility has received security approval from the Department to access EDSS or
the other registries and provides identifying information satisfactory to the
Department to determine that the person to whom the information relates is
currently being treated by or under the care of the licensed health care
provider or health care institution; and
ii) the
disclosure of the EDSS or other registries' information is in the best
interests of the person to whom treatment or care is being provided or will
contribute to the protection of the public health.
C) Disclosure
may take place using electronic means compliant with HIPAA security and privacy
standards. The Department will prescribe the use of a health information
exchange to achieve these purposes when a health information exchange is
available.
D) A
person or institution to whom information is furnished or to whom access to
records has been given shall not divulge any part of the records so as to
disclose the identity of the person to whom the information or record relates,
except as necessary for the treatment of a case or carrier or for the
protection of the health of others.
e) Section 8-2101 of the Code of Civil Procedure explains the
confidential character of reports obtained for medical studies. The Department
and other agencies specified in that Section may collect certain information
and require reporting of certain diseases and conditions for medical studies.
The law provides for confidentiality of these reports, prohibits disclosure of
all data obtained except that which is necessary for the purpose of the
specific study, provides that data shall not be admissible as evidence, and
provides that the furnishing of information in the course of a medical study
shall not subject any informant to any action for damages. No patient,
patient's relatives, or patient's friends named in any medical study shall be
interviewed for the purpose of the study unless consent of the attending
physician and surgeon is first obtained. (Section 8-2104 of the Code of
Civil Procedure)
f) The local health authority shall notify the Department upon
issuing any order for isolation, quarantine or closure. The notification shall
be made by telephone within three hours after the order is issued unless the
Department directs otherwise.
g) Identifiable data may be released to the extent necessary for
the treatment, control, investigation or prevention of diseases and conditions
dangerous to the public health. Identifiable data can be shared for conditions
of public health significance, e.g., as permitted by HIPAA regulations, the
Medical Studies Act, and the Health Statistics Act. As described in the Health
Statistics Act, a Department-approved Institutional Review Board, or its
equivalent on the protection of human subjects in research, will review and
approve requests from researchers for individually identifiable data.
h) Procedures Involving Emergency Care Provider
Every person,
employer or local government employing persons rendering emergency care shall
designate a contact person or "designated officer" to receive reports
from the local health authority. The employer shall assure that the designated
officer has sufficient training to carry out the duties described in subsection
(i), which shall include appropriate procedures for follow-up after
occupational exposures to specific diseases specified in subsection (i).
i) The following apply to meningococcal disease,
infectious pulmonary or laryngeal tuberculosis, diphtheria, plague (Yersinia
pestis), rabies, hemorrhagic fevers (e.g., Lassa, Marburg, monkeypox, and
Ebola) or an environmental infectious disease risk, such as hantavirus or
histoplasmosis, in the location where the patient was attended to:
1) Health
care providers and health care facilities shall, when reporting these diseases,
determine and include as part of their report whether an emergency care
provider was involved in pre-hospital care for the patient.
2) Health
care providers and health care facilities shall report to the local health
authority and may relay the diagnosis of these diseases directly to the
emergency care providers or the designated officer specified in subsection
(i)(3), but shall not disclose the identity or addresses of the person having
the disease or otherwise refer specifically to the person.
3) Upon
receiving a report of a notifiable disease or condition as defined in this
subsection (i), the designated officer shall notify all out-of-hospital care
providers, including, but not limited to: emergency medical personnel,
firefighters, law enforcement officers, corrections officers, probation
officers, or other current or former personnel of the employer who may have
been exposed to the reportable disease.
4) The
designated officer shall inform the personnel only of the reportable disease,
the fact of possible exposure and the appropriate follow-up procedures. The
designated officer shall not inform the personnel of the identity or addresses
of the person having the reportable disease or otherwise refer specifically to
the person.
(Source: Amended at 47 Ill. Reg. 18112,
effective November 22, 2023)
SUBPART D: DETAILED PROCEDURES FOR THE CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.290 ACUTE FLACCID MYELITIS (AFM) (REPORTABLE BY TELEPHONE AS SOON AS POSSIBLE, WITHIN 24 HOURS)
Section 690.290 Acute Flaccid
Myelitis (AFM) (Reportable by telephone as soon as possible, within 24 hours)
a) Control
of Case
No general
restrictions.
b) Control
of Contacts
No general
restrictions.
c) Laboratory
and Other Reporting
Laboratories shall report to the
local health authority patients who have a positive result on any laboratory or
other diagnostic test indicative of and specific for detecting acute flaccid
myelitis, including MRI test results.
(Source: Former Section 690.290
repealed at 12 Ill. Reg. 10045, effective May 27, 1988; new Section 690.290
added at 47 Ill. Reg. 18112, effective November 22, 2023)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.295 ANY UNUSUAL CASE OF A DISEASE OR CONDITION NOT LISTED IN THIS PART THAT IS OF URGENT PUBLIC HEALTH SIGNIFICANCE (REPORTABLE BY TELEPHONE IMMEDIATELY (WITHIN THREE HOURS))
Section 690.295 Any Unusual
Case of a Disease or Condition Not Listed in this Part that is of Urgent Public
Health Significance (Reportable by telephone immediately (within three hours))
a) Control
of Case
Cases shall be evaluated to determine
the need for isolation in a health care setting or at the person's current residence
or alternative location. The isolation precautions followed shall be based on
the most likely pathogen.
b) Control
of Contacts
Contacts shall be evaluated to determine
the need for quarantine and/or for symptoms monitoring follow-up for a period
of time following exposure.
c) Persons who identify a single case of a rare or significant disease
or condition shall report the case to the local
health authority. This may include, but is not limited to, cowpox, Reye's syndrome,
glanders, amoebic meningoencephalitis, orf, monkeypox, hemorrhagic fever
viruses, infection from a laboratory-acquired recombinant organism, or any
disease or condition non-indigenous to the United States.
d) The local health
authority shall implement appropriate control measures.
e) Laboratory
Reporting
1) Laboratories
shall report to the local health authority any disease or condition of public
health significance that may indicate a public health hazard.
2) Laboratories
shall retain specimens or isolates for a minimum of 30 days and submit to the
Department upon request.
(Source: Amended at 47 Ill.
Reg. 18112, effective November 22, 2023)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: COMMUNICABLE DISEASE CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF COMMUNICABLE DISEASES CODE
SECTION 690.300 AMEBIASIS (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN 7 DAYS) (REPEALED)
Section 690.300 Amebiasis
(Reportable by mail, telephone, facsimile or electronically as soon as
possible, within 7 days) (Repealed)
(Source: Repealed at 32 Ill.
Reg. 3777, effective March 3, 2008)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: COMMUNICABLE DISEASE CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF COMMUNICABLE DISEASES CODE
SECTION 690.310 ANIMAL BITES (REPORTABLE BY MAIL OR TELEPHONE AS SOON AS POSSIBLE, WITHIN 7 DAYS) (REPEALED)
Section 690.310 Animal Bites
(Reportable by mail or telephone as soon as possible, within 7 days) (Repealed)
(Source: Repealed at 25 Ill. Reg. 3937, effective April 1, 2001)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.320 ANTHRAX (REPORTABLE BY TELEPHONE IMMEDIATELY, WITHIN THREE HOURS, UPON INITIAL CLINICAL SUSPICION OF THE DISEASE)
Section 690.320 Anthrax
(Reportable by telephone immediately, within three hours, upon initial clinical
suspicion of the disease)
a) Control of Case
1) A
search shall be made for history of exposure to infected animals or animal
products and traced to the place of origin. The reporting of exposures other
than from infected animals or animal products shall follow the reportable
guidelines for suspect bioterrorist threat or event (see Section 690.800). The
Department will refer information about exposures indicating a domestic animal
source within the United States to the Illinois Department of Agriculture and
the United States Department of Agriculture.
2) All
anthrax cases shall be reviewed carefully for consideration of a bioterrorist
event.
b) Control of Contacts
No
restrictions.
c) Laboratory Reporting
1) Laboratories shall report to the local health authority patients
who have a positive or suspect positive result on any laboratory test
indicative of and specific for detecting Bacillus anthracis infection.
2) Laboratories shall forward clinical materials suspected to be
positive for Bacillus anthracis to the Department's laboratory.
3) Laboratories shall report and submit to the Department's
laboratory any food, animal or environmental test results positive for Bacillus
anthracis from a case or outbreak investigation.
(Source: Amended at 47 Ill.
Reg. 18112, effective November 22, 2023)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.322 ARBOVIRAL INFECTIONS (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE, OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN THREE DAYS)
Section
690.322 Arboviral Infections (Reportable by mail, telephone, facsimile, or
electronically as soon as possible, within three days)
a) Control of Case
No general restrictions.
b) Control of Contacts
Sexual contacts of Zika cases should be educated about the
risk of sexual transmission of Zika virus.
c) General Measures
Local health authorities shall inquire of all persons for
whom an arbovirus test result is positive about recent blood donation. If a
donation took place within two days to four weeks prior to onset of symptoms of
donors with any suspected or known arbovirus infection, and 30 days prior to
the onset of symptoms of donors with suspected West Nile virus infection, the
local health authority shall notify the director of the donation facility of
the donor's name, date of birth, sex, zip code, state of residence, date of
donation, date of illness onset, and arboviral test results. Patient
information, including test results received by donation facilities, shall be
confidential.
d) Laboratory Reporting
1) Laboratories shall report to
the local health authority patients who have a positive result on any
laboratory test indicative of and specific for detecting acute arboviral
infection and any positive laboratory test indicative of and specific for
detecting arboviral infection in a blood donor, and organ or tissue recipient.
2) Laboratories shall hold
arboviral specimens with a positive or equivocal IgM antibody reactive with the
suspected agent for a minimum of 30 days. Upon request by the Department
or local health authority, laboratories forward to the Department's laboratory
clinical materials from patients who are suspected of having an acute arboviral
infection.
(Source:
Amended at 47 Ill. Reg. 18112, effective November 22, 2023)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: COMMUNICABLE DISEASE CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF COMMUNICABLE DISEASES CODE
SECTION 690.325 BLASTOMYCOSIS (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN 7 DAYS) (REPEALED)
Section 690.325
Blastomycosis (Reportable by mail, telephone, facsimile or electronically as
soon as possible, within 7 days) (Repealed)
(Source: Repealed at 32 Ill.
Reg. 3777, effective March 3, 2008)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.327 BOTULISM, FOODBORNE, INTESTINAL BOTULISM (FORMERLY INFANT), WOUND, OR OTHER (REPORTABLE BY TELEPHONE IMMEDIATELY, WITHIN THREE HOURS UPON INITIAL CLINICAL SUSPICION OF THE DISEASE FOR FOODBORNE BOTULISM OR WITHIN 24 HOURS BY TELEPHONE, FACSIMILE, OR ELECTRONICALLY FOR OTHER TYPES)
Section 690.327 Botulism,
Foodborne, Intestinal Botulism (Formerly Infant), Wound, or Other (Reportable
by telephone immediately, within three hours upon initial clinical suspicion of
the disease for foodborne botulism or within 24 hours by telephone, facsimile, or
electronically for other types)
a) Control of Case
1) There are no restrictions on cases.
2) After consultation with and approval by the Department, serum,
stool or gastric aspirates from suspect cases should be collected.
3) Requests for botulinum antitoxin for treatment of suspect wound
or foodborne botulism shall be made through the Department. Botulism immune
globulin for treatment of infants with botulism can be requested through the
Department.
4) Suspect
cases shall be investigated immediately, within three hours after initial
clinical suspicion.
5) Any
food, drug or other material suspected of having botulinum toxin should be
confiscated and held until consultation with the Department can occur and
testing needs determined.
b) Control of Contacts
1) No restrictions.
2) For
foodborne botulism, persons who may have eaten food suspected of containing
botulinum toxin should seek medical consultation.
c) Laboratory Reporting
1) Laboratories shall report to the local health authority all
persons for whom botulism testing is requested and all food and environmental
specimens that may be associated with an outbreak.
2) Laboratories shall report and submit to the Department's
laboratory any food samples resulting from a botulism investigation.
(Source: Amended at 47 Ill. Reg.
18112, effective November 22, 2023)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.330 BRUCELLOSIS (REPORTABLE BY TELEPHONE AS SOON AS POSSIBLE (WITHIN 24 HOURS), UNLESS SUSPECT BIOTERRORIST EVENT OR PART OF AN OUTBREAK, THEN REPORTABLE IMMEDIATELY (WITHIN THREE HOURS) BY TELEPHONE)
Section 690.330 Brucellosis
(Reportable by telephone as soon as possible (within 24 hours), unless suspect
bioterrorist event or part of an outbreak, then reportable immediately (within three
hours) by telephone)
a) Control of Case
1) All Brucella cases shall be investigated with information
collected on travel to a country where Brucella is endemic, consumption of
unpasteurized dairy products from outside the U.S. or possible exposures
related to a bioterrorism event.
2) If a suspect
domestic animal source within the United States is identified, the Department
will provide this information to the Illinois Department of Agriculture and the
United States Department of Agriculture. If a suspect wild animal source is
identified the Department will provide this information to the Illinois
Department of Natural Resources.
b) Control of Contacts
No
restrictions.
c) Laboratory Reporting and Laboratory Worker Exposures
1) Laboratories shall report to the local health authority all
patients who have a positive result on any laboratory test indicative of and
specific for detecting Brucella species infection.
2) Laboratories shall forward clinical materials, including, but
not limited to, cultures, isolates or serum, suspected to be positive for
Brucella species to the Department's laboratory.
3) Laboratories shall report and submit to the Department's
laboratory any food, animal or environmental test results positive for Brucella
species from a case or outbreak investigation.
4) Laboratories shall cooperate with public health authorities to
identify any exposed laboratory workers.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.335 CAMPYLOBACTERIOSIS (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE, OR ELECTRONICALLY, WITHIN THREE DAYS)
Section 690.335
Campylobacteriosis (Reportable by mail, telephone, facsimile, or
electronically, within three days)
a) Control of Case
1) No specific
restrictions.
2) Health Care Workers, Food Handlers or Persons in Sensitive
Occupations shall not work until vomiting and diarrhea has resolved for at
least 48 hours without the use of antidiarrheal medications.
3) Persons shall be excluded from school or child care facilities
until fever, vomiting, and diarrhea has resolved for at least 24 hours without
the use of fever-reducing or antidiarrheal medications.
b) Control of Contacts
No specific restriction
of contacts.
c) Sale
of Food, Milk. Etc. (See Section 690.30(b).)
d) Laboratory
Reporting
1) Laboratories
shall report to the local health authority patients from whom Campylobacter has
been isolated or patients who have a positive result on any laboratory test
indicative of and specific for detecting Campylobacter infection.
2) Laboratories
shall report and submit to the Department's laboratory any food, animal or human
clinical Campylobacter specimens or environmental samples resulting from an
outbreak investigation.
(Source: Amended at 48 Ill. Reg. 4098,
effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: COMMUNICABLE DISEASE CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF COMMUNICABLE DISEASES CODE
SECTION 690.340 CHANCROID (REPEALED)
Section 690.340 Chancroid
(Repealed)
(Source: Repealed at 12 Ill. Reg. 10045, effective May 27, 1988)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.350 CHICKENPOX (VARICELLA) (REPORTABLE BY TELEPHONE, FACSIMILE, OR ELECTRONICALLY WITHIN 24 HOURS)
Section 690.350 Chickenpox
(Varicella) (Reportable by telephone, facsimile, or electronically
within 24 hours)
a) Control of Case
1) Children shall be excluded from school or child care
facilities for a minimum of five days after the appearance of eruption (with
day zero being the first day of rash appearance) or until vesicles become dry,
whichever is longer.
2) Adults
shall be excluded from school and the workplace for a minimum of five days
after the appearance of eruption (with day zero being the first day of rash
appearance) or until vesicles become dry/crusted, whichever is longer.
b) Control of Contacts
Susceptible
contacts in a health care setting shall be quarantined, as necessary, until the
incubation period has elapsed to prevent exposure of immuno-compromised
patients. Local health authorities, in consultation with the Department, may
require additional exclusions if there is reason to believe these
recommendations will prevent further spread of the disease. (See Section
2310-15 of the Department of Public Health Powers and Duties Law)
c) Health
Care Facility Guidance
1) All
exposed susceptible patients shall be discharged as soon as feasible. All
exposed susceptible patients who cannot be discharged shall be placed in airborne
infection isolation and contact precautions from days 8 to 21 following
exposure to the index case. For patients who receive
varicella-specific immune globulin, airborne infection isolation and
contact precautions shall be followed until day 28.
2) All exposed susceptible health care workers shall be
restricted from patient contact from days 8 to 21 following exposure to an
index case; this restriction shall be extended to 28 days for persons receiving
varicella-specific immune globulin.
d) Laboratory
Reporting
Laboratories shall report to the
local health authority all patients who have a positive result on any
laboratory test indicative of and specific for detecting varicella infection.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.360 CHOLERA (TOXIGENIC VIBRIO CHOLERAE O1 OR O139) (REPORTABLE BY TELEPHONE, FACSIMILE, OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN 24 HOURS)
Section 690.360 Cholera (Toxigenic
Vibrio cholerae O1 or O139) (Reportable by telephone, facsimile, or
electronically as soon as possible, within 24 hours)
a) Control of Case
1) Food
Handlers or Persons in Sensitive Occupations, Not Including Health Care
Workers. Cases with cholera shall not work as food handlers or in sensitive
occupations until diarrhea has ceased for at least 48 hours and three consecutive
negative stool specimens are obtained. Specimens shall be obtained following
clinical recovery of the patient, at least 24 hours apart and not sooner than
48 hours after the last dose of antimicrobials, if administered. Specimens
shall be submitted within one week after notification.
2) Health Care Workers or Those Who Work in Occupations Requiring
Standard Precautions. Local health departments may require specimens from
health care workers or those who work in occupations requiring standard
precautions if there is reason to believe that specimen testing is necessary
(e.g., the nature of the work, including feeding patients,
assisting patients with eating, providing or preparing meals for patients,
denture or oral care, hygienic practices of the worker, dispensing or
administering oral medications, or as part of an investigation of a cluster). Specimens
shall be obtained following clinical recovery of the patient, at least 24 hours
apart and not sooner than 48 hours after the last dose of antimicrobials, if
administered. Specimens shall begin to be submitted within one week after
notification, or the individual shall be restricted from patient care. When
specimen submission is required, health care workers who feed patients or
assist patients with eating, meals, provide denture or oral care or dispense or
administer oral medications, shall be restricted from these duties until three
negative stool specimens are obtained or the public health authority determines
that monitoring is no longer warranted.
3) Persons shall be excluded from school or child care facilities
until vomiting and diarrhea has resolved for at least 24 hours without the use
of antidiarrheal medication.
b) Control of Contacts
Contacts
should be asked about symptoms during the period of household exposure and for five
days after last exposure.
1) Contacts Who Have Not Had Diarrhea During the Previous Four Weeks
A) Food
Handlers or Persons in Sensitive Occupations, Not Including Health Care Workers
i) There
are no work restrictions while submitting release specimens for contacts who
are employed as food handlers or in sensitive occupations and who have had no
symptoms of cholera infection during the previous four weeks.
ii) Contacts
to cases of cholera who are employed as food handlers or in sensitive
occupations shall submit three consecutive negative stool specimens obtained at
least 24 hours apart and not sooner than 48 hours after the last dose of
antimicrobials, if administered. These contacts shall be restricted from their
occupations if they do not begin submitting release specimens within one week
after notification. Release specimens shall be submitted at least once per week
until three consecutive negative specimens are obtained, or the individual
shall be restricted from working.
iii) If
any of the three release specimens is positive for toxigenic Vibrio cholera O1
or O139, contacts shall be considered cases and shall be required to comply
with restrictions on returning to work in subsection (a)(2).
B) Health
Care Workers
Local health authorities may
require specimens from health care workers or those who work in occupations
requiring standard precautions if there is reason to believe that specimen
testing is necessary (e.g., the nature of the work, including feeding patients,
assisting patients with eating, providing or preparing meals for patients,
denture or oral care, hygienic practices of the worker, dispensing or
administering oral medications, or as part of an investigation of a cluster). Specimens
shall be obtained at least 24 hours apart. Specimens shall begin to be
submitted within one week after notification, or the individual shall be
restricted from patient care.
2) Contacts Who Currently Have, or Have Had, Diarrhea During the
Previous Four Weeks
A) Food
Handlers or Persons in Sensitive Occupations, Not Including Health Care Workers
i) All
contacts to cases of cholera employed as food handlers or in sensitive
occupations, and who currently have diarrhea or have had diarrhea during the
previous four weeks, shall not work in their occupations until diarrhea has
ceased for at least 48 hours and they have submitted three consecutive negative
stool specimens. Specimens shall be obtained following clinical recovery of
the patient, at least 24 hours apart and not sooner than 48 hours after the
last dose of antimicrobials, if administered. Specimens shall begin to be
submitted within one week after notification.
ii) If
any of the three release specimens is positive for toxigenic Vibrio cholerae,
contacts shall be considered cases and shall comply with subsection (a)(1).
B) Health
Care Workers
Local health authorities may
require specimens from health care workers or those who work in occupations
requiring standard precautions if there is reason to believe specimen testing
is necessary (e.g., the nature of the work, including feeding patients,
assisting patients with eating, providing or preparing meals for patients,
denture or oral care, hygienic practices of the worker, dispensing or
administering oral medications, or as part of an investigation of a cluster). Specimens
shall be obtained following clinical recovery of the patient, at least 24 hours
apart and not sooner than 48 hours after the last dose of antimicrobials, if
administered. Specimens shall begin to be submitted within one week after
notification, or the individual shall be restricted from patient care. When
specimen submission is required, health care workers who feed patients or
assist patients with eating or meals, provide denture or oral care, or dispense
or administer oral medications shall be restricted from these duties until
three negative stool specimens are obtained, or the public health authority
determines that monitoring is no longer warranted.
c) Sale of Food, Milk, etc. (See Section 690.30(b).)
d) Laboratory Reporting
1) Laboratories shall report to the local health authority all
patients who have a positive result on any laboratory test indicative of and
specific for detecting Vibrio cholerae infection.
2) Laboratories shall forward clinical materials suspected to be
positive for Vibrio cholerae to the Department's laboratory in accordance with
the Department's specimen submission criteria, which can be accessed at:
https://dph.illinois.gov/topics-services/lab-testing-services/general-requirements.html.
3) Laboratories
shall report and submit to the Department's laboratory any food or
environmental Vibrio cholerae isolates resulting from an outbreak
investigation.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.361 CORONAVIRUS, NOVEL, INCLUDING SEVERE ACUTE RESPIRATORY SYNDROME (SARS) AND MIDDLE EASTERN RESPIRATORY SYNDROME (MERS) (REPORTABLE BY TELEPHONE IMMEDIATELY (WITHIN 3 HOURS) UPON INITIAL CLINICAL SUSPICION OF THE DISEASE)
Section
690.361 Coronavirus, Novel, including Severe Acute Respiratory Syndrome (SARS)
and Middle Eastern Respiratory Syndrome (MERS) (Reportable by telephone
immediately (within 3 hours) upon initial clinical suspicion of the disease)
a) Control
of Case
1) The
Department will make recommendations as information becomes known about the
transmissibility of the novel coronavirus.
2) If
present rules are not adequate, alternative recommendations may be issued. See
Section 690.100(d).
3) When a
case or suspected case is isolated in the home or in any other non-hospital
setting, isolation procedures shall comply with Section 690.20(a)(4).
b) Control
of Contacts
1) The
Department will make recommendations for control of contacts based on
transmissibility and severity of the illness caused by the novel strain.
Observation and monitoring procedures shall comply with Section 690.20(a)(4).
2) Close
contacts of cases may be quarantined. Quarantine procedures shall comply with
Subpart I and Section 690.20(a)(4).
c) Laboratory
Reporting
1) Laboratories
shall report all persons with novel coronavirus (suspected or confirmed) to the
local health authority. Laboratories shall report to the local health authority
patients who have a positive result on any laboratory test indicative of and
specific for detecting novel coronavirus.
2) If
deemed necessary by the Department or local health authority, based on factors
such as number or severity of cases, novelty of the virus, or need to test for
treatment purposes, laboratories shall forward clinical specimens to the
Department's laboratory for further testing.
(Source: Amended at 48 Ill. Reg. 4098,
effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.362 CRONOBACTER, INCLUDING C. SAKAZAKII AND C. MALONATICUS, IN INFANTS YOUNGER THAN 12 MONTHS OF AGE (REPORTABLE BY TELEPHONE, FACSIMILE, OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN 24 HOURS)
Section
690.362 Cronobacter, including C. sakazakii and C. malonaticus, in infants
younger than 12 months of age (Reportable by telephone, facsimile, or
electronically as soon as possible, within 24 hours)
a) Control of Case
No specific restrictions.
b) Control of Contacts
No specific restrictions.
c) Laboratory Reporting
1) Laboratories shall report to
the local health authority patients younger than 12 months of age from whom
Cronobacter spp. has been isolated in a clinical specimen.
2) Laboratories shall forward to
the Department's laboratory isolates from infants younger than 12 months of age
from whom Cronobacter spp. has been isolated in a clinical specimen.
3) Laboratories shall report and
submit to the Department's laboratory any food or environmental samples
resulting from a Cronobacter case investigation.
(Source: Former Section 690.362 repealed at 43 Ill. Reg.
2386, effective February 8, 2019; new Section 690.362 added at 48 Ill. Reg. 4098,
effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.365 CRYPTOSPORIDIOSIS (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE, OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN THREE DAYS)
Section 690.365
Cryptosporidiosis (Reportable by mail, telephone, facsimile, or electronically
as soon as possible, within three days)
a) Control of Case
1) Cases with diarrhea shall not work as food handlers, health
care workers, or in sensitive occupations until diarrhea has ceased for at
least 48 hours. No release specimens are required before returning to work for
persons employed as food handlers or in sensitive occupations.
2) Cases
shall avoid swimming in public recreational water venues (e.g., swimming pools,
whirlpool spas, wading pools, water parks, interactive fountains, lakes) while
symptomatic and for two weeks after cessation of diarrhea.
3) Cases
shall not work in jobs or do volunteer work where immersion in recreational
water may occur while symptomatic and for two weeks after cessation of
diarrhea.
4) Cases
shall be excluded from school or child care facilities until diarrhea has
resolved for at least 24 hours without the use of antidiarrheal medications.
b) Control of Contacts
Contacts with
diarrhea shall not work as food handlers, health care workers, or in sensitive
occupations until absence of diarrhea for 48 hours.
c) Sale
of Food, Milk, etc. (See Section 690.30(b).)
d) Laboratory Reporting
1) Laboratories
shall report to the local health authority patients who have a positive result
on any laboratory test indicative of and specific for detecting Cryptosporidium
species infection.
2) Laboratories
shall report and submit to the Department's laboratory any Cryptosporidium
positive stool, animal, food or environmental samples resulting from an
outbreak investigation or upon request.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.368 CYCLOSPORIASIS (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE, OR ELECTRONICALLY, WITHIN THREE DAYS)
Section 690.368
Cyclosporiasis (Reportable by mail, telephone, facsimile, or electronically,
within three days)
a) Control of Case
No
restrictions are required for food handlers, health care workers or those in
sensitive occupations.
b) Control of Contacts
1) No specific restrictions.
2) Contacts who have had similar exposures as cases should see a health
care provider if diarrhea develops.
c) Laboratory Reporting
1) Laboratories
shall report to the local health authority patients who have a positive result
on any laboratory test indicative of and specific for detecting Cyclospora
infection.
2) Laboratories
shall report and submit to the Department's laboratory any Cyclospora positive stool,
food or environmental samples resulting from an outbreak investigation or upon
request.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: COMMUNICABLE DISEASE CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF COMMUNICABLE DISEASES CODE
SECTION 690.370 DIARRHEA OF THE NEWBORN (REPORTABLE BY TELEPHONE AS SOON AS POSSIBLE, WITHIN 24 HOURS) (REPEALED)
Section 690.370 Diarrhea of
the Newborn (Reportable by telephone as soon as possible, within 24 hours) (Repealed)
(Source: Repealed at 32 Ill.
Reg. 3777, effective March 3, 2008)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.380 DIPHTHERIA (REPORTABLE BY TELEPHONE IMMEDIATELY, WITHIN THREE HOURS, UPON INITIAL CLINICAL SUSPICION OR LABORATORY TEST ORDER)
Section 690.380 Diphtheria
(Reportable by telephone immediately, within three hours, upon initial clinical
suspicion or laboratory test order)
a) Control of Case
1) The
case shall be isolated until two successive cultures from both throat and nose
(and skin lesions in cutaneous diphtheria) are negative for diphtheria bacilli
or when a virulence test proves the bacilli to be avirulent. The first culture
shall be taken not less than 24 hours after completion of antibiotic therapy,
and the second culture shall be taken not less than 24 hours after the first.
If culturing is unavailable or impractical, isolation may be ended after 14
days of effective appropriate antimicrobial therapy.
2) Use
of diphtheria antitoxin should be considered in addition to antibiotic therapy
when clinical findings and consultation with Department personnel support use.
b) Control of Contacts
1) All close contacts (household members and other persons
directly exposed to oral secretions of patients with pharyngeal presentation or
with direct contact with secretions from lesions with cutaneous presentation) shall
be cultured from the nose and from the throat, provided antibiotic prophylaxis,
and placed under surveillance for seven to ten days.
2) Contacts
who are food handlers, health care workers, or in sensitive occupations shall
not work in these occupations until shown, by two successive negative cultures
from the nose and from the throat, not to be carriers, and permission is
granted in writing by the local health authority. The first culture shall be
taken not less than 24 hours after completion of antibiotic therapy, and the
second culture shall be taken not less than 24 hours after the first.
3) All
previously immunized close contacts should receive a booster dose of diphtheria
toxoid-containing vaccines if more than five years have elapsed since their
last dose. If the close contact is a child and has not received the fourth
primary dose or booster, a booster is recommended even if the time since the
last dose was received within the past five years.
4) If close contacts have received fewer than three doses of
diphtheria toxoid-containing vaccines, or vaccination history is unknown, an
immediate dose of diphtheria toxoid-containing vaccine should be given and the
primary series completed.
5) All contacts found to be carriers by positive culture at screening
shall be handled in the same manner as cases according to subsection (a)(1) and
managed as indicated in subsection (c).
6) In a susceptible
individual who has been exposed, antitoxin should be considered. This should
be followed immediately with active immunization.
c) Control of Carriers
1) Carriers discovered as the result of epidemiological follow-up
of a known case or in another way (screening, etc.) shall be handled in the
same manner as cases. (See subsections (a)(1) and (2).)
2) All
previously immunized carriers should receive a booster dose of diphtheria
toxoid-containing vaccines if more than one year has elapsed since their last
dose.
3) Cultures
should be repeated a minimum of two weeks after completion of antimicrobials to
assure eradication of the organism.
4) Carriers
who have received fewer than three doses of diphtheria toxoid- containing
vaccines, or whose vaccination history is unknown, should receive an immediate
dose of diphtheria toxoid-containing vaccine and complete the primary series.
d) Sale of Food, Milk, etc. (See Section 690.30(b).)
e) Laboratory Reporting
1) Laboratories
shall report to the local health authority patients who have a positive result
on any laboratory test indicative of and specific for detecting Corynebacterium
diphtheriae infection.
2) Laboratories shall forward clinical materials positive for
Corynebacterium diphtheriae to the Department's laboratory for toxicity
testing.
3) Laboratories shall report any request for suspected diphtheria
testing as soon as possible, within three hours.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.385 EHRLICHIOSIS, HUMAN GRANULOCYTOTROPIC ANAPLASMOSIS (HGA) (SEE TICKBORNE INFECTIONS)
Section 690.385
Ehrlichiosis, Human Granulocytotropic anaplasmosis (HGA) (See Tickborne Infections)
See Tickborne
Infections (Section 690.698).
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.386 EHRLICHIOSIS, HUMAN MONOCYTOTROPIC (HME) (SEE TICKBORNE INFECTIONS)
Section 690.386
Ehrlichiosis, Human Monocytotropic (HME) (See Tickborne Infections)
See Tickborne Infections
(Section 690.698).
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: COMMUNICABLE DISEASE CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF COMMUNICABLE DISEASES CODE
SECTION 690.390 ENCEPHALITIS (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN 7 DAYS) (REPEALED)
Section 690.390 Encephalitis
(Reportable by mail, telephone, facsimile or electronically as soon as
possible, within 7 days) (Repealed)
(Source: Repealed at 32 Ill.
Reg. 3777, effective March 3, 2008)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.400 ESCHERICHIA COLI INFECTIONS (E. COLI O157 AND OTHER SHIGA TOXIN-PRODUCING E. COLI) (REPORTABLE BY TELEPHONE, FACSIMILE, OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN 24 HOURS)
Section 690.400 Escherichia
coli Infections (E. coli O157 and Other Shiga Toxin-Producing E. coli)
(Reportable by telephone, facsimile, or electronically as soon as possible,
within 24 hours)
a) Control of Case
1) Food
Handlers or Persons in Sensitive Occupations, Not Including Health Care Workers
Cases with E. coli infections
caused by E. coli O157 or other Shiga toxin-producing E. coli shall not work as
food handlers or in sensitive occupations until diarrhea has ceased for at
least 48 hours and two consecutive negative stool specimens are obtained.
Specimens shall be obtained following clinical recovery of the patient, at
least 24 hours apart, and not sooner than 48 hours after the last dose of
antimicrobials, if administered. Specimens shall be submitted beginning within
one week after notification.
2) Health
Care Workers
Local health authorities may
require specimens from health care workers or those who work in occupations
requiring standard precautions if there is reason to believe that specimen
testing is necessary (e.g., the nature of the work, including feeding patients,
assisting patients with eating, providing or preparing meals for patients,
denture or oral care, hygienic practices of the worker, dispensing or
administering oral medications, or as part of an investigation of a cluster). Specimens
shall be obtained following clinical recovery, at least 24 hours apart and not
sooner than 48 hours after the last dose of antimicrobials, if administered.
Specimens shall begin to be submitted within one week after notification, or
the individual shall be restricted from patient care. When specimen submission
is required, health care workers who feed patients or assist patients with
eating, provide or prepare meals for patients, provide denture or oral care or
dispense or administer medications, shall be restricted from these duties until
two negative stool specimens are obtained or the public health authority
determines based on the number of cases, risk of further infections, or other
factors that monitoring is no longer warranted.
3) Day
Care Attendees
Cases of E. coli O157 or other
Shiga toxin-producing E. coli shall be excluded from attending a child care
facility, an adult day care facility or a facility for the developmentally
disabled if below the age of five years or incontinent of stool until two
consecutive negative stool specimens are obtained. Specimens shall be obtained
following clinical recovery of the patient, at least 24 hours apart, and not
sooner than 48 hours after the last dose of antimicrobials, if administered.
4) Cases
shall avoid swimming in public recreational water venues (e.g., swimming pools,
whirlpool spas, wading pools, water parks, interactive fountains, lakes) while
symptomatic and for two weeks after the date diarrhea has ceased.
b) Control
of Contacts
1) Contacts Who Have Not Had Diarrhea During the Previous Four
Weeks
A) Food
Handlers or Persons in Sensitive Occupations, Not Including Health Care Workers
i) There
are no work restrictions while submitting release specimens for contacts who
are employed as food handlers or in sensitive occupations and who have had no
symptoms of E. coli infections caused by E. coli O157 or other Shiga
toxin-producing E. coli strains during the previous four weeks.
ii) Contacts
to cases with E. coli infections caused by O157 or other Shiga toxin-producing E.
coli strains who are employed as food handlers or in sensitive occupations
shall submit two consecutive negative stool specimens obtained at least 24
hours apart and not sooner than 48 hours after the last dose of antimicrobials,
if administered. These contacts shall be restricted from their occupations if
they do not begin submitting release specimens within one week after
notification. Release specimens shall be submitted at least once per week until
two consecutive negative specimens are obtained, or the individual shall be
restricted from working.
iii) If
either of the two release specimens is positive for E. coli infection caused by
O157 or other Shiga toxin-producing strains, contacts shall be considered cases
and shall comply with subsection (a)(1).
B) Health
Care Workers
Local health authorities may
require specimens from health care workers or those who work in occupations
requiring standard precautions if there is reason to believe that specimen
testing is necessary (e.g., the nature of the work, including feeding patients,
assisting patients with eating, providing or preparing meals for patients,
denture or oral care, hygienic practices of the worker, dispensing or
administering medications, or as part of an investigation of a cluster). Specimens
shall be obtained at least 24 hours apart. Specimens shall begin to be
submitted within one week after notification, or the individual shall be
restricted from patient care.
2) Contacts Who Currently Have Diarrhea or Have Had Diarrhea
During the Previous Four Weeks
A) Food
Handlers or Persons in Sensitive Occupations, Not Including Health Care Workers
i) All
contacts to cases of E. coli infections caused by O157 or other Shiga
toxin-producing E. coli strains employed as food handlers or in sensitive
occupations, and who currently have diarrhea or have had diarrhea during the
previous four weeks, shall not work in their occupations until diarrhea has
ceased for at least 48 hours and they have submitted two consecutive negative
stool specimens. Specimens shall be obtained following clinical recovery of
the patient, at least 24 hours apart, and not sooner than 48 hours after the
last dose of antimicrobials, if administered. Specimens shall begin to be
submitted within one week after notification.
ii) If
either of the two release specimens is positive for E. coli infection caused by
O157 or other Shiga toxin-producing E. coli strains, contacts shall be
considered cases and shall comply with subsection (a)(1).
B) Health
Care Workers
Local health authorities may
require specimens from health care workers or those who work in occupations
requiring standard precautions if there is reason to believe that specimen
testing is necessary (e.g., the nature of the work, including feeding patients,
assisting patients with eating, providing or preparing meals for patients,
denture or oral care, hygienic practices of the worker, dispensing or
administering oral medications, or as part of an investigation of a cluster). Specimens
shall be obtained following clinical recovery of the patient, at least 24 hours
apart and not sooner than 48 hours after the last dose of antimicrobials, if
administered. Specimens shall begin to be submitted within one week after
notification, or the individual shall be restricted from patient care. When
specimen submission is required, health care workers who feed patients or
assist patients with eating, provide or prepare meals for patients, provide
denture or oral care, or dispense or administer oral medications, shall be
restricted from these duties until two negative stool specimens are obtained,
or if the public health authority determines based on case numbers, risk of
further infections or other factors that monitoring is no longer warranted.
C) Day
Care Attendees
Contacts to cases of E. coli O157
or other Shiga toxin-producing E. coli strains who currently have or have had
diarrhea during the previous four weeks who attend a child care facility, an
adult day care facility or a facility for the developmentally disabled and are
below the age of five years or incontinent of stool shall submit two
consecutive negative stool specimens. Specimens shall be obtained following
clinical recovery of the patient, at least 24 hours apart, and not sooner than
48 hours after the last dose of antimicrobials, if administered. Release
specimens shall be submitted within one week after notification, or the
individual shall be restricted from attendance. If either of the two specimens
is positive for E. coli infection caused by O157 or other Shiga toxin producing
E. coli strains, contacts shall be considered cases and shall comply with
subsection (a)(3).
c) Shiga Toxin Producing E. coli Outbreaks at a Facility Where
Food Handling Occurs
When an outbreak occurs in a
facility where food handling exists, food handlers at the facility shall be
considered contacts to cases and shall submit two consecutive negative stool
specimens obtained at least 24 hours apart and not sooner than 48 hours after
the last dose of antimicrobials, if administered. Local health authorities, in
consultation with the Department, may require two consecutive negative
specimens from food handlers before food handlers return to work, if there is
reason to believe these individuals may be the source of the illness or could
transmit disease. In all other outbreaks where there is no reason to believe
these individuals may be the source of the illness or could transmit disease,
food handlers shall be restricted from their occupations if they do not begin
submitting specimens within one week after notification, and specimens shall be
submitted at least once per week until two consecutive negative specimens are
obtained, or the individual shall be restricted from food handling until the
public health authority determines that monitoring is no longer warranted.
d) Sale of Food, Milk, etc. (See Section 690.30(b).)
e) Laboratory Reporting
1) Laboratories shall report to the local health authority all
patients who have a positive result from a stool specimen or any laboratory
test indicative of and specific for detecting Escherichia coli O157, other
Shiga toxin-producing E. coli.
2) Laboratories shall submit E. coli O157 or other Shiga toxin-producing
isolates, broth or specimens to the Department's laboratory in accordance with
the Department's specimen submission criteria, which can be accessed at:
https://dph.illinois.gov/topics-services/lab-testing-services/general-requirements.html.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: COMMUNICABLE DISEASE CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF COMMUNICABLE DISEASES CODE
SECTION 690.410 FOODBORNE OR WATERBORNE ILLNESS (REPORTABLE BY TELEPHONE OR FACSIMILE AS SOON AS POSSIBLE, WITHIN 24 HOURS) (REPEALED)
Section 690.410 Foodborne or
Waterborne Illness (Reportable by telephone or facsimile as soon as possible,
within 24 hours) (Repealed)
(Source: Repealed at 38 Ill.
Reg. 5533, effective February 11, 2014)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: COMMUNICABLE DISEASE CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF COMMUNICABLE DISEASES CODE
SECTION 690.420 GIARDIASIS (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN 7 DAYS) (REPEALED)
Section 690.420 Giardiasis
(Reportable by mail, telephone, facsimile or electronically as soon as
possible, within 7 days) (Repealed)
(Source: Repealed at 38 Ill.
Reg. 5533, effective February 11, 2014)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: COMMUNICABLE DISEASE CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF COMMUNICABLE DISEASES CODE
SECTION 690.430 GONORRHEA (REPEALED)
Section 690.430 Gonorrhea
(Repealed)
(Source: Repealed at 12 Ill. Reg. 10045, effective May 27, 1988)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: COMMUNICABLE DISEASE CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF COMMUNICABLE DISEASES CODE
SECTION 690.440 GRANULOMA INGUINALE (REPEALED)
Section 690.440 Granuloma
Inguinale (Repealed)
(Source: Repealed at 12 Ill. Reg. 10045, effective May 27, 1988)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.441 HAEMOPHILUS INFLUENZAE, INVASIVE DISEASE (REPORTABLE BY TELEPHONE, FACSIMILE, OR ELECTRONICALLY, WITHIN 24 HOURS)
Section 690.441 Haemophilus Influenzae,
Invasive Disease (Reportable by telephone, facsimile, or electronically, within
24 hours)
a) Control of Case
No specific restrictions.
b) Control of Contacts
1) No specific restrictions.
2) When
a case of Haemophilus influenzae type b occurs, chemoprophylaxis shall be
considered for all household contacts in households in which there is a child less
than 12 months of age (other than the index case) who has not received the
primary series of Hib conjugate vaccine; or for all household contacts in
households with a child less than four years of age who is inadequately
immunized against Haemophilus influenzae type b; or for all household contacts
in households with an immunocompromised child regardless of immunization
status.
3) When two
or more cases of Haemophilus influenzae type b invasive disease occur in a
child care facility within 60 days and unimmunized or incompletely immunized
children attend the child care facility, administration of chemoprophylaxis to
all attendees and staff having sufficient contact is indicated.
c) Laboratory Reporting
1) Laboratories shall report to the local health authority when
Haemophilus influenzae (any type) has been cultured from a normally sterile
site or patients who have a positive result on any other laboratory test
indicative of and specific for detecting invasive Haemophilus influenzae (any
type).
2) Laboratories shall forward clinical materials from a normally
sterile site that are positive for Haemophilus influenzae (any type) to the
Department's laboratory.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.442 HANTAVIRUS PULMONARY SYNDROME (REPORTABLE BY TELEPHONE AS SOON AS POSSIBLE, WITHIN 24 HOURS)
Section 690.442 Hantavirus
Pulmonary Syndrome (Reportable by telephone as soon as possible, within 24
hours)
a) Control of Case
The local
health authority shall investigate cases to determine locations of exposure to
rodents, which can transmit hantavirus, in the two months before illness onset.
b) Control of Contacts
No specific restrictions.
c) Laboratory Reporting
1) Laboratories
shall report to the local health authority patients who have a positive result
on any laboratory test indicative of and specific for detecting hantavirus
infection.
2) Laboratories
shall forward clinical materials positive for hantavirus to the Department's
laboratory.
3) Upon
request of the Department, veterinary diagnostic laboratories shall send animal
specimens from a suspect outbreak or emerging virus situation to the
Department.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.444 HEMOLYTIC UREMIC SYNDROME, POST-DIARRHEAL (REPORTABLE BY TELEPHONE, FACSIMILE, OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN 24 HOURS)
Section 690.444 Hemolytic
Uremic Syndrome, Post-diarrheal (Reportable by telephone, facsimile, or
electronically as soon as possible, within 24 hours)
a) Control of Case. See applicable Section of this Part
concerning the disease that preceded the HUS (Section 690.400 or 690.640).
b) Control of Contacts. See applicable Section of this Part
concerning the disease that preceded the HUS (Section 690.400 or 690.640).
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.450 HEPATITIS A (REPORTABLE BY TELEPHONE, FACSIMILE, OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN 24 HOURS)
Section 690.450 Hepatitis A
(Reportable by telephone, facsimile, or electronically as soon as possible,
within 24 hours)
a) Control of Case
1) Cases
shall be excluded from work as food handlers, health care workers or in
sensitive occupations nor attend or work in childcare facilities for seven days
after onset of jaundice or two weeks after onset of initial symptoms, if
jaundice is not present.
2) Health
care workers shall not have direct patient contact or contact with patient
environment and food for seven days after onset of jaundice or two weeks after
onset of initial symptoms if jaundice is not present.
b) Control
of Contacts
1) A susceptible contact to an infectious case of hepatitis A,
who is also a food handler, shall be excluded from work as a food handler for
28 days from the last exposure to the infectious case unless the contact has
received a hepatitis A prophylaxis for the current exposure within 14 days of
exposure. Food handling employees who work with the case are also considered
contacts.
2) Local
health authorities may require exclusions for susceptible contacts who work in
sensitive occupations or as health care workers or susceptible contacts who
attend or work in a child care facility for 28 days from last exposure to an
infectious case unless the contact has received hepatitis A prophylaxis for the
current exposure within 14 days of exposure, and if there is a reason to
believe exclusions are necessary (e.g., the nature of the work, including, but
not limited to, feeding or oral care, hygienic practices of the worker, or as
part of the investigation of a cluster).
3) Guidelines
for hepatitis A vaccine or immune globulin (IG) administration for susceptible
contacts are specified in Section 690.20(b)(1), (2) and (3).
4) Administration
of IG is not recommended for symptomatic contacts, but testing is recommended
to verify the diagnosis.
c) Sale of Food, Milk, etc. (See Section 690.30(b).)
d) Laboratory Reporting
1) Laboratories shall report to the local health authority patients
who have a positive result on any laboratory test indicative of and specific
for detecting acute hepatitis A infection, including IgM specific antibodies to
the hepatitis A virus (total antibody is not reportable). Upon request,
laboratories shall provide liver function test results for suspect cases of hepatitis
A.
2) Laboratories shall hold any serum specimens positive for
hepatitis A IgM antibodies for up to 14 days after collection, and upon
request, submit clinical specimens to the Department's laboratory for further
testing.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.451 HEPATITIS B (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE, OR ELECTRONICALLY, WITHIN THREE DAYS)
Section 690.451 Hepatitis B
(Reportable by mail, telephone, facsimile, or electronically, within three
days)
a) Control of Cases and Carriers
No specific restrictions.
b) Control of Contacts
1) Contacts to cases or
carriers of hepatitis B should be tested for susceptibility to hepatitis B
virus.
2) A person who is a sexual, household, or other at-risk contact
to cases or carriers of hepatitis B should be tested for susceptibility to
hepatitis B virus and given prophylaxis in accordance with the Recommended
Childhood Immunization Schedule and recommendations of the Advisory Committee
on Immunization Practices (ACIP). (Guidelines for hepatitis B prophylaxis are
specified in Section 690.20(a)(1), (2), (11) and (13).
3) Infants born to mothers
who are hepatitis B surface antigen (HBsAg) positive should receive hepatitis B
vaccine and hepatitis B immune globulin (0.5 mL) within 12 hours after
birth, both by intramuscular injection, but at different sites. The infant
should be tested for the presence of HBsAg and anti-HBs following completion of
the hepatitis B vaccine series (3-4 doses). Testing should be completed no
sooner than nine months of age and at least one to two months after the last
dose of the regular series of the vaccine. If required (because of failure to
develop immunity after the regular series), additional doses should be given in
accordance with the current published Advisory Committee on Immunization
Practices recommendations as referenced in Section 690.20(a)(11).
4) Susceptible contacts who have been exposed in a manner that allows for
transmission of hepatitis B should receive hepatitis B immune globulin (HBIG)
as early as possible following exposure, preferably within 24 hours but not
more than 14 days after exposure.
5) Susceptible
contacts should begin hepatitis B vaccination.
c) General Measures
1) All pregnant persons should be
tested for HBsAg during an early prenatal visit, or when they present to a
hospital for delivery if prenatal serologic results are not available. Pregnant
persons who are at high risk for hepatitis B infection (recent history of
sexually transmitted infection, multiple sex partners, injection drug use, or
other possible risks of hepatitis B infection) should be re-tested upon
admission.
2) Health care providers shall refer pregnant persons who are HBsAg
positive within seven days after receipt of the test result to a local health
authority for counseling and recommendations on testing and immunizing
contacts.
3) Persons previously known to test positive for HBsAg shall not donate
blood.
4) Prevention of Hepatitis B Virus Infection in the United
States: Recommendations of the Advisory Committee on Immunization Practices
(see Section 690.20(a)(8)), Updated CDC Recommendations for the Management of
Hepatitis B Virus – Infected Health-Care Providers and Students (see Section
690.20(a)(1)) and the Updated U.S. Public Health Service Guidelines for the
Management of Occupational Exposures to HBV, HCV and HIV and Recommendations
for Postexposure Prophylaxis (see Section 690.20(a)(2)) shall be followed.
d) Laboratory
Reporting
Laboratories shall report to the
local health authority patients who:
1) Are
pregnant with evidence of acute or chronic hepatitis B infection (surface
antigen positive).
2) Have
a positive IgM anti-HBc, HBsAg, HBeAg, or HBV nucleic acid test (including
genotype), along with any positive reportable hepatitis B virus result,
including viral hepatitis markers (positive or detected), and alanine
aminostransferase (ALT) results.
3) Have a negative or non-detected result for HBsAg or HBV DNA,
or negative anti-HBc IgM results.
4) Are children younger than 5 years old, with any HBsAg and
HBsAb results (positive, negative, and indeterminate).
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.452 HEPATITIS C, ACUTE INFECTION, PERINATAL AND NON-ACUTE CONFIRMED INFECTION (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE, OR ELECTRONICALLY, WITHIN THREE DAYS)
Section 690.452 Hepatitis C,
Acute Infection, Perinatal and Non-acute Confirmed Infection (Reportable by
mail, telephone, facsimile, or electronically, within three days)
a) Control of Case
No specific restrictions.
b) Control of Contacts
Infants born
to mothers who are hepatitis C positive shall be tested for the presence of
hepatitis C by polymerase chain reaction (PCR) or any other supplemental or
confirmatory test. Testing shall be done no sooner than two months of age.
After 18 months of age, the infant shall be tested for the presence of
hepatitis C by anti-HCV testing by immunoassay.
c) Laboratory Reporting
1) Laboratories shall report to the local health authority
patients who receive the following tests:
A) Anti-HCV
testing (both positive and negative results) by immunoassay (e.g., enzyme
immunoassay, chemiluminescence immunoassay), or
B) Hepatitis C by polymerase chain reaction (PCR) (both positive
and negative) or any other supplemental or confirmatory test that may be used.
C) Hepatitis C by antigen test (both positive and negative) or any
other supplemental or confirmatory tests that may be used.
2) Laboratories shall report results of the alanine
aminotransferase (ALT) testing that are closest in time to the date of the
positive hepatitis C result. Results shall be reported concurrently with the
positive immunoassay, PCR, immunoblot or other confirmatory test results.
3) Laboratories shall report viral genotype results (when
performed).
4) Laboratories shall report results of the total bilirubin
testing that are closest in time to the date of the positive hepatitis C result.
Results shall be reported concurrently with the positive immunoassay, PCR,
immunoblot or other confirmatory test results.
d) General Measures
All pregnant
persons should be tested for hepatitis C with reflex testing (HCV
AB-RNA-genotype) during first trimester or first prenatal visit, and when they
present to a hospital or other facility for delivery if prenatal serologic
results are not available. Pregnant persons who are at high risk for hepatitis
C infection (recent history of sexually transmitted infection, multiple sexual
partners, injection drug use, or other possible risks of hepatitis C infection)
should be re-tested upon admission to the hospital prior to delivery.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: COMMUNICABLE DISEASE CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF COMMUNICABLE DISEASES CODE
SECTION 690.453 HEPATITIS, VIRAL, OTHER (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE OR ELECTRONICALLY, WITHIN 7 DAYS) (REPEALED)
Section 690.453 Hepatitis,
Viral, Other (Reportable by mail, telephone, facsimile or electronically,
within 7 days) (Repealed)
(Source: Repealed at 32 Ill.
Reg. 3777, effective March 3, 2008)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.460 HISTOPLASMOSIS (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE, OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN THREE DAYS)
Section 690.460
Histoplasmosis (Reportable by mail, telephone, facsimile, or electronically as
soon as possible, within three days)
a) Control of Case
No specific restrictions.
b) Control of Contacts
No specific restrictions.
c) Laboratory Reporting
1) Laboratories
shall report to the local health authority patients from whom Histoplasma
capsulatum has been cultured or patients who have a positive result on any
other laboratory test indicative of and specific for detecting Histoplasma
capsulatum infection.
2) Laboratories
shall report and submit to the Department's laboratory any environmental
Histoplasma samples resulting from an outbreak investigation.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.465 INFLUENZA, (LABORATORY CONFIRMED DEATHS IN PERSONS YOUNGER THAN 18 YEARS OF AGE) (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE, OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN THREE DAYS)
Section
690.465 Influenza, (Laboratory Confirmed Deaths in persons younger than 18 years
of age) (Reportable by mail, telephone, facsimile, or electronically as soon as
possible, within three days)
a) The death of a child younger
than 18 years of age with laboratory-confirmed influenza (including laboratory-based
rapid tests) shall be reported (see Section 690.200 for mandated reporters and
reporting procedures). There should have been no period of recovery between
illness and death.
b) Laboratory
Laboratories shall forward to the Department's laboratory
clinical materials that are positive for influenza from influenza death cases
younger than 18 years of age upon request.
(Source: Amended at 48 Ill.
Reg. 15900, effective October 23, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.468 INFLUENZA (LABORATORY CONFIRMED TESTING VIA ELR ONLY AND INTENSIVE CARE UNIT ADMISSIONS) (REPORTABLE BY TELEPHONE, FACSIMILE, OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN THREE DAYS)
Section 690.468 Influenza
(Laboratory Confirmed Testing via ELR only and Intensive Care Unit Admissions)
(Reportable by telephone, facsimile, or electronically as soon as possible,
within three days)
a) Control of Case
No specific restrictions.
b) Control of Contacts
The Department will recommend
control of contacts based on transmissibility and severity of the illness
caused by the influenza strain.
c) Laboratory Reporting
1) Laboratories
shall report all positive laboratory results for influenza to the Department
via the Department's electronic lab reporting (ELR) system in a manner and on a
schedule prescribed by the Department. Laboratories unable to submit results to
the Department via the Department's ELR shall contact the Department for
instructions on how to submit results.
2) Upon
request, laboratories shall forward clinical materials to the Department's
laboratory.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.469 INFLUENZA A, NOVEL OR VARIANT VIRUS (REPORTABLE BY TELEPHONE IMMEDIATELY, WITHIN THREE HOURS UPON INITIAL CLINICAL SUSPICION OR LABORATORY TEST ORDER)
Section 690.469 Influenza A, Novel or Variant Virus
(Reportable by telephone immediately, within three hours upon initial clinical
suspicion or laboratory test order)
a) Control of Case
1) The
Department will make recommendations as information becomes known about the
transmissibility of the novel or variant influenza virus.
2) If
present rules are not adequate, alternative requirements may be issued. See
Section 690.100(d).
b) Control of Contacts
1) The
Department will make recommendations for control of contacts based on
transmissibility and severity of the illness caused by the novel or variant
influenza A strain.
2) Health
care workers caring for patients with a novel or variant strain of influenza A shall
be monitored for illness by the health care facility, in collaboration with the
local health authority.
3) Emergency
medical responders and persons on farms, zoos, county fairs, households or
other locations where novel or variant influenza A viruses have been identified
in animals, such as swine or poultry, will be monitored for illness during
their exposure and for an appropriate time after exposure.
c) Laboratory Testing and
Reporting
1) Virus
isolation studies on respiratory specimens from individuals with suspect
variant influenza infection should not be performed by clinical laboratories
unless approved by the Department.
2) Laboratories
shall forward clinical materials to the Department's laboratory.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: COMMUNICABLE DISEASE CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF COMMUNICABLE DISEASES CODE
SECTION 690.470 INTESTINAL WORMS (REPORTABLE BY MAIL OR TELEPHONE AS SOON AS POSSIBLE, WITHIN 7 DAYS) (REPEALED)
Section 690.470 Intestinal
Worms (Reportable by mail or telephone as soon as possible, within 7 days)
(Repealed)
(Source: Repealed at 25 Ill. Reg. 3937, effective April 1, 2001)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.475 LEGIONELLOSIS (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE, OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN THREE DAYS)
Section 690.475 Legionellosis
(Reportable by mail, telephone, facsimile, or electronically as soon as
possible, within three days)
a) Control of Case
No specific
restrictions.
b) Control of Contacts
No specific restrictions.
c) Laboratory Reporting
1) Laboratories shall report to the local health authority
patients from whom Legionella species is cultured or patients who have a
positive result on any other laboratory test indicative of and specific for
detecting Legionella infection.
2) Laboratories shall forward clinical materials positive for
Legionella isolates to the Department's laboratory.
3) Laboratories
shall report and submit to the Department's laboratory any environmental
Legionella isolates resulting from a cluster or health care-associated
infection investigation, or upon request.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: COMMUNICABLE DISEASE CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF COMMUNICABLE DISEASES CODE
SECTION 690.480 LEPROSY (HANSEN'S DISEASE) (INFECTIOUS AND NON-INFECTIOUS CASES ARE REPORTABLE) (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN SEVEN DAYS) (REPEALED)
Section 690.480 Leprosy
(Hansen's Disease) (Infectious and Non-infectious Cases are Reportable)
(Reportable by mail, telephone, facsimile or electronically as soon as
possible, within seven days) (Repealed)
(Source: Repealed at 43 Ill.
Reg. 2386, effective February 8, 2019)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.490 LEPTOSPIROSIS (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE, OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN THREE DAYS)
Section 690.490
Leptospirosis (Reportable by mail, telephone, facsimile, or electronically as
soon as possible, within three days)
a) Control of Case
1) No
specific restrictions.
2) If a cluster of cases is identified, the local health authority
shall look for evidence of infection from a common environmental source.
b) Control of Contacts
No specific restrictions.
c) Laboratory Reporting
1) Laboratories
shall report to the local health authority patients from whom Leptospira species
has been cultured or patients who have a positive result on any laboratory test
indicative of and specific for detecting Leptospira species infection.
2) Laboratories
shall forward clinical materials positive for Leptospira to the Department's
laboratory.
3) Laboratories
shall report and submit to the Department's laboratory any positive
environmental or animal samples resulting from an outbreak investigation.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.495 LISTERIOSIS (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE, OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN THREE DAYS)
Section 690.495 Listeriosis (Reportable
by mail, telephone, facsimile, or electronically as soon as possible, within three
days)
a) Control of Case
1) No
specific restrictions.
2) If a cluster of cases is identified, the local health authority
shall look for evidence of infection from a common source.
b) Control of Contacts
No specific restrictions.
c) Laboratory Reporting
1) Laboratories shall report to the local health authority
patients from whom Listeria monocytogenes has been cultured from a normally
sterile site or patients who have a positive result on any other laboratory
test indicative of and specific for detecting Listeria monocytogenes.
2) Laboratories shall forward to the Department's laboratory clinical
materials that are positive for Listeria monocytogenes.
3) Laboratories
shall report and submit to the Department's laboratory any food or
environmental Listeria isolates resulting from an outbreak investigation, or
upon request.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: COMMUNICABLE DISEASE CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF COMMUNICABLE DISEASES CODE
SECTION 690.500 LYMPHOGRANULOMA VENEREUM (LYMPHOGRAULOMA INGUINALE; LYMPHOPATHIA VENEREUM) (REPEALED)
Section 690.500
Lymphogranuloma Venereum (Lymphograuloma Inguinale; Lymphopathia Venereum)
(Repealed)
(Source: Repealed at 12 Ill. Reg. 10045, effective May 27, 1988)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.505 LYME DISEASE (SEE TICKBORNE INFECTIONS)
Section 690.505 Lyme Disease
(See Tickborne Infections)
See Tickborne Infections
(Section 690.698).
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.510 MALARIA (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE, OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN THREE DAYS)
Section 690.510 Malaria
(Reportable by mail, telephone, facsimile, or electronically as soon as
possible, within three days)
a) Control of Case
No specific restrictions.
b) Control of Contacts
No specific restrictions.
c) Laboratory Reporting
1) Laboratories shall report to the local health authority,
regardless of the patients' state or country of residence, patients who have a
positive or presumptive positive result on any laboratory test indicative of
and specific for detecting Plasmodium species infection.
2) If laboratories are not able to speciate malaria specimens,
laboratories shall forward clinical materials, including, but not limited to, whole
blood, slides and images found to contain malaria parasites to the Department's
laboratory for speciation. Whole blood samples are the preferred specimen type.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.520 MEASLES, SUSPECT, PROBABLE OR CONFIRMED (REPORTABLE BY TELEPHONE IMMEDIATELY, WITHIN THREE HOURS, UPON INITIAL CLINICAL SUSPICION OR LABORATORY TEST)
Section 690.520 Measles,
Suspect, Probable or Confirmed (Reportable by telephone immediately, within
three hours, upon initial clinical suspicion or laboratory test)
a) Control of Case
All cases,
including suspect cases, with measles shall isolate themselves at home and
shall be excluded from school, work, and child care facilities for at least four
days after appearance of the rash.
b) Control of Contacts
1) All susceptible contacts (persons six
months of age or older who have not yet received a total of two doses of
measles-containing vaccine) and who have no contraindications to receiving the
vaccine) should begin vaccination with live virus measles vaccine. Vaccine
should be administered within 72 hours after exposure for maximal protection.
When vaccine is given prior to the first birthday, a second dose shall be given
on or after the first birthday, and a third dose at least 28 days later but
prior to school entry (four to six years of age).
2) Susceptible
contacts with high risk of severe illnesses or complications or with measles
vaccine contraindications should be given immune globulin (IG) within six days
after exposure. IG is not indicated for contacts who have received one dose of
vaccine at 12 months of age or older unless they are immunocompromised. Live
measles vaccine shall be given five to six months later to those IG recipients,
provided that the vaccine is not contraindicated.
3) Susceptible
contacts who have not received vaccination within the appropriate time frame
shall be excluded from school, workplace, child care facility, or other
facilities until 21 days after last exposure to a measles case.
4) Susceptible
contacts receiving IG as post-exposure prophylaxis shall isolate themselves at
home and shall be excluded from school, work, and child care facilities for at
least 21 days after the last exposure to a measles case. Local health
authorities may increase this period of exclusion to 28 days if investigation
warrants additional measures to prevent further spread of the disease.
5) Health
care personnel with direct patient contact shall be required to provide proof
of immunity to measles as described by the Advisory Committee on Immunization
Practices (see Section 690.20(a)(7)).
6) Susceptible health care workers exposed to measles shall
receive a dose of measles-mumps-rubella (MMR) vaccine and shall be removed from
all patient contact and excluded from the facility from the fifth to the 21st
day after the exposure. Susceptible health care workers may return to work on
the 22nd day after exposure. Regardless of vaccination history,
personnel who become ill with prodromal symptoms or rash shall be removed from
all patient contact and excluded immediately from the facility until four days
after the onset of the rash.
7) Local health authorities, in consultation with the Department,
may require additional exclusions if there is reason to believe these
recommendations will prevent further spread of the disease. (See Section
2310-15 of the Department of Public Health Powers and Duties Law)
c) Laboratory Testing and Reporting
1) Laboratories shall report to the local health authority any
request for measles diagnostic testing, including molecular (PCR) testing and
measles IgM, immediately, within three hours. Confirmatory (PCR) testing for
measles shall be conducted at IDPH Public Health Laboratories.
2) Laboratories shall report to the local health authority
patients who have a positive result on any laboratory test indicative of and
specific for detecting measles virus infection.
3) Laboratories shall forward clinical materials that are PCR
positive for measles to the Department's laboratory.
4) Upon
request, laboratories performing PCR testing shall forward specimens with Not
Detected results for measles to the Department's laboratory.
(Source: Amended at 48 Ill.
Reg. 15900, effective October 23, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.530 MELIOIDOSIS DUE TO BURKHOLDERIA PSEUDOMALLEI (REPORTABLE BY TELEPHONE OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN 24 HOURS)
Section 690.530 Melioidosis due to Burkholderia
pseudomallei (Reportable by telephone or electronically as soon as possible,
within 24 hours)
a) Control of Case
1) No specific
restrictions.
2) A
search will be made for a source if international travel is not reported.
3) All
melioidosis cases shall be reviewed carefully for consideration of a
bioterrorist event.
b) Control of Contacts
No specific restrictions.
c) Laboratory Reporting
1) Laboratories
shall report to the local health authority patients who have a positive or
suspect positive result on any laboratory test indicative of and specific for
detecting Burkholderia pseudomallei infection.
2) Laboratories
shall forward clinical materials suspected to be positive for Burkholderia
pseudomallei to the Department's laboratory.
3) Laboratories
shall report and submit to the Department's laboratory any product, or
environmental test results positive for Burkholderia pseudomallei from a case
or outbreak investigation.
(Source: Former Section 690.530
repealed at 32 Ill. Reg. 3777, effective March 3, 2008; new Section 690.530
added at 48 Ill. Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.540 MULTI-DRUG RESISTANT ORGANISMS CONSIDERED TO BE OF EPIDEMIOLOGIC IMPORTANCE DUE TO EITHER SEVERITY OF CLINICAL DISEASE, POTENTIAL FOR TRANSMISSION OF GENETIC ELEMENTS, OR OPPORTUNITIES FOR EFFECTIVE CONTROL EFFORTS (REPORTABLE BY TELEPHONE, FACSIMILE, OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN THREE DAYS)
Section 690.540 Multi-drug
Resistant Organisms Considered to be of Epidemiologic Importance Due to Either
Severity of Clinical Disease, Potential for Transmission of Genetic Elements,
or Opportunities for Effective Control Efforts (Reportable by telephone,
facsimile, or electronically as soon as possible, within three days)
a) Control
of Case
1) Patients in health care facilities, including, but not limited
to, long-term acute care hospitals and skilled nursing facilities, should
comply with the local health authority's recommendations for control measures
as supported by the Department or the CDC procedures and best practices for
control of transmission.
2) The health care facility shall confirm notification to a
receiving facility before admission or transfer and include in admission and
transfer orders if the patient is positive for an MDRO, or if the patient was screened
or tested for an MDRO and the results are pending and make notification of
results once testing is completed.
b) Control
of Contacts
Health care
facilities should comply with the local health authority's recommendations for prevention
and control measures and outbreak response as supported by the Department or
CDC procedures and best practices for control of transmission.
c) Laboratory
Testing
1) Laboratories shall report to the local health authority
patients who have a positive result on any laboratory test indicative of and
specific for detecting infection or colonization of MDROs deemed to be of
public health importance.
2) If deemed necessary by the local health authority or the
Department, laboratories shall forward clinical or environmental specimens to
the Department's laboratory for further testing.
(Source: Former
Section 690.540 repealed at 18 Ill. Reg. 10158, effective July 15, 1994; new
Section 690.540 added at 48 Ill. Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.550 MUMPS (REPORTABLE BY TELEPHONE, FACSIMILE, OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN 24 HOURS)
Section 690.550 Mumps
(Reportable by telephone, facsimile, or electronically as soon as possible,
within 24 hours)
a) Control of Case
Suspect,
probable, and confirmed cases as defined in Section 690.10 shall be excluded
from school, child care facilities or the workplace until five days after onset
of symptoms (parotitis).
b) Control of Contacts
1) Susceptible close contacts to confirmed and probable cases shall
be excluded from school, child care facilities or the workplace from days 12
through 25 after exposure.
2) Susceptible close contacts to suspect cases in health-care
facilities, or other settings where residents are at high risk for transmission
or severe disease, as determined by the local health authority, shall be
excluded from the facility from day 12 though day 25 after exposure.
3) In outbreak settings, exclusion shall be extended from day 12
of the first case through day 25 after the last case's parotitis onset.
4) Local health authorities, in consultation with the Department,
may require additional exclusions if there is reason to believe these
recommendations will prevent further spread of disease. (See Section 2310-15 of
the Department of Public Health Powers and Duties Law)
c) Laboratory Reporting
Laboratories
shall report to the local health authority patients who have a positive result
on any laboratory test indicative of and specific for detecting mumps virus
infection.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.555 NEISSERIA MENINGITIDIS, INVASIVE DISEASE AND PURPURA FULMINANS (REPORTABLE BY TELEPHONE, FACSIMILE, OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN 24 HOURS)
Section 690.555 Neisseria
meningitidis, Invasive Disease and Purpura Fulminans (Reportable by
telephone, facsimile, or electronically as soon as possible, within 24 hours)
a) Control of Case
No specific restrictions.
b) Control of Contacts
1) No specific
restrictions.
2) Vaccination
should be considered in selected outbreaks following guidelines in Section 690.20(a)(3).
3) Vaccination
recommendations for children, adolescents and young adults are specified in
Section 690.20(a)(3).
4) Recommendations
for chemoprophylaxis of close contacts are specified in Section 690.20(a)(3).
c) Laboratory Reporting
1) Laboratories shall report to the local health authority patients
who have a positive result on any laboratory test indicative of and specific
for detecting Neisseria meningitidis from a normally sterile site.
2) Persons with purpura fulminans diagnosed by a physician shall
also be reported to the local health authority.
3) Laboratories shall forward clinical materials from a normally
sterile site that are positive for Neisseria meningitidis to the Department's
laboratory.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: COMMUNICABLE DISEASE CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF COMMUNICABLE DISEASES CODE
SECTION 690.560 OPHTHALMIA NEONATORUM (GONOCOCCAL) (REPORTABLE BY MAIL OR TELEPHONE AS SOON AS POSSIBLE, WITHIN 7 DAYS) (REPEALED)
Section 690.560 Ophthalmia
Neonatorum (Gonococcal) (Reportable by mail or telephone as soon as possible,
within 7 days) (Repealed)
(Source: Repealed at 25 Ill. Reg. 3937, effective April 1, 2001)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.565 ANY SUSPECTED OR CONFIRMED OUTBREAK OF A DISEASE OF KNOWN OR UNKNOWN ETIOLOGY THAT MAY BE A DANGER TO THE PUBLIC HEALTH, WHETHER THE DISEASE, INFECTION, MICROORGANISM, OR CONDITION IS SPECIFIED IN THE RULE (INCLUDING, BUT NOT LIMITED TO, FOODBORNE, HEALTHCARE-ASSOCIATED, ZOONOTIC DISEASE OR WATERBORNE OUTBREAKS) (REPORTABLE BY TELEPHONE OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN 24 HOURS)
Section 690.565 Any Suspected or Confirmed Outbreak of a
Disease of Known or Unknown Etiology that may be a Danger to the Public Health,
Whether the Disease, Infection, Microorganism, or Condition is specified in the
Rule (Including, but Not Limited to, Foodborne, Healthcare-associated, Zoonotic
Disease or Waterborne Outbreaks) (Reportable by telephone or electronically as
soon as possible, within 24 hours)
a) Investigation of
Outbreaks
1) Any
pattern of cases, or increased incidence of any illness beyond the expected
number of cases in a given period, that may indicate an outbreak, including but
not limited to suspected or confirmed outbreaks of foodborne or waterborne
disease, or outbreaks transmitted by laboratory acquisition, animal contact,
person-to-person contact, inhalation or other transmission method, or in
healthcare settings due to breaches in infection control practices shall be
reported to the local health authority within 24 hours. Outbreaks shall be
reported if there is a public health significance to the event, including, but
not limited to, evidence of severe illness (deaths or hospitalizations),
institutional outbreaks, outbreaks involving a population at increased risk for
severe complications, outbreaks of reportable diseases or conditions, outbreaks
of unknown etiology, outbreaks with a controllable source, or outbreaks which
are very large or rapidly progressing or if there is the possibility of
transmission to humans from animals.
2) All suspected
or confirmed foodborne outbreaks shall be investigated by the local health
authority where the food was prepared, or by the Department or another relevant
agency (e.g., Illinois Department of Agriculture, federal Food and Drug
Administration) if the local authority does not have regulatory authority or is
unable to perform the investigation. If multiple jurisdictions are involved,
the jurisdiction where the food was prepared shall be in charge of the
investigation unless determined otherwise. All suspected or confirmed
outbreaks not caused by foodborne transmission shall be investigated by the
local health authority where the exposure occurred.
3) If
the investigation determines that an outbreak has occurred, the jurisdiction in
charge of the investigation shall enter the outbreak within 24 hours from notification
from outbreak facility or cluster detection by local health authority into the
Department's ORS. Within 30 days of the end of the outbreak investigation, the
final information shall be entered into ORS.
4) When
outbreaks occur in any business, organization, institution, private home or
health care facility, staff in the establishment where the outbreak occurred
may be considered to be contacts to cases and may be required by the local
health authority to submit specimens for testing.
5) Reporting
entities, as defined in Section 690.200(a)(1), are required to report any known
or suspected common-source outbreaks and any intoxication caused by marine
organisms, including paralytic shellfish poisoning, ciguatera and scombroid.
6) See
Section 690.20(a)(9) and (a)(10) for guidance on the control of viral
gastroenteritis outbreaks.
b) Control of Cases
1) Cases
shall be evaluated to determine the need for isolation in a health care setting
or at the person's residence. The isolation precautions followed shall be based
on the most likely pathogen.
2) Persons
who become ill due to an outbreak shall comply with restrictions specific to
each etiologic agent addressed in this Part.
3) If
the etiologic agent responsible for a foodborne or waterborne outbreak is not
addressed in this Part and diarrhea or vomiting of infectious or unknown cause
is present, food handlers and persons in sensitive occupations, including
health care workers, who are ill shall not work until 48 hours after diarrhea
or vomiting has resolved.
4) Persons
with draining skin lesions shall not work as food handlers unless the drainage
is contained by a dressing and lesions are not on the hands or forearms.
5) The
Director shall request certain reports of clinical diagnosis of disease in
animals, reports of laboratory tests on animals, and clinical materials from
animals when investigation based upon veterinarian and veterinary medical
laboratory reports will assist in the prevention and control of disease among
humans.
c) Control of Contacts
1) Contacts
shall be evaluated to determine the need for quarantine or for symptom monitoring/follow-up
by the local public health authority for the appropriate time period.
2) Contacts
to persons who become ill due to an outbreak shall comply with restrictions
specific to each etiologic agent.
d) The local health
authority shall implement appropriate control measures.
e) Sale of Food, Milk, etc.
(See Section 690.30(b).)
f) Laboratory Reporting
1) Laboratories
shall report to the local health authority clinical, animal, environmental or
food specimens that have a positive result on a laboratory test indicative of
and specific for detecting any outbreak of public health significance.
2) Laboratories
shall submit to the Department's laboratory any positive clinical, food,
environmental or animal samples resulting from an outbreak investigation.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.570 PLAGUE (REPORTABLE BY TELEPHONE IMMEDIATELY, WITHIN THREE HOURS UPON INITIAL CLINICAL SUSPICION OF THE DISEASE)
Section 690.570 Plague
(Reportable by telephone immediately, within three hours upon initial
clinical suspicion of the disease)
a) Control of Case
1) Cases, their clothing, their living quarters and any pets
shall be treated to eliminate fleas.
2) The Department will refer information about animal contacts to
the Illinois Department of Agriculture or the Illinois Department of Natural
Resources for follow-up.
b) Control of Contacts
1) Contacts to pneumonic plague cases shall be offered
chemoprophylaxis and monitored daily for seven days by the local health
authority or other designated individual (e.g., congregate care staff or
hospital personnel).
2) Contacts to bubonic plague shall be monitored daily for seven
days by the local health authority or other designated individual (e.g.,
congregate care staff or hospital personnel) for evidence of illness and may be
offered chemoprophylaxis if likely to have been exposed to a primary source
such as rodent fleas.
c) Laboratory Reporting
1) Laboratories shall report to the local health authority
patients from whom Yersinia pestis is cultured or patients who have a positive
result on any other laboratory test indicative of and specific for detecting
Yersinia pestis infection.
2) Laboratories shall forward clinical materials that are suspect
or confirmed positive for Yersinia pestis to the Department's laboratory.
3) Laboratories shall report any Yersinia pestis isolates from
animals or the environment during an individual case or outbreak investigation.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.580 POLIOMYELITIS (REPORTABLE BY TELEPHONE IMMEDIATELY (WITHIN THREE HOURS) UPON INITIAL CLINICAL SUSPICION OF THE DISEASE)
Section 690.580
Poliomyelitis (Reportable by telephone immediately (within three hours) upon
initial clinical suspicion of the disease)
a) Control of Case
Cases or
suspected cases with polio who are not in the hospital shall isolate themselves
at home, and shall be excluded from school, work, or any child care facility
until the Department determines the person is no longer infectious and isolation
is no longer needed.
b) Control of Contacts
1) Vaccination should begin for all susceptible contacts who have
previously not been adequately immunized, even though these contacts may have
already been infected.
2) Susceptible contacts should be monitored for compatible
symptoms for two weeks after date of last exposure.
c) Laboratory Reporting
1) Laboratories shall report to the local health authority
patients who have a positive result on any laboratory test indicative of and
specific for detecting polio virus infection.
2) Laboratories shall forward clinical materials to the
Department's laboratory for confirmation within 24 hours after preliminary
findings.
3) Laboratories shall report to the local health authority any
request for polio testing as soon as possible, within three hours.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.590 PSITTACOSIS (ORNITHOSIS) DUE TO CHLAMYDIA PSITTACI (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE, OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN THREE DAYS)
Section 690.590 Psittacosis
(Ornithosis) Due to Chlamydia psittaci (Reportable by mail, telephone,
facsimile, or electronically as soon as possible, within three days)
a) Control of Case
No specific restrictions.
b) Control of Contacts
No specific restrictions.
c) Control of Infected Birds and Premises
If information
on the source of the birds suspected of exposing the person to psittacosis is
available, the Department will provide this information to the Illinois
Department of Agriculture for follow-up.
d) Laboratory Reporting
1) Laboratories shall report to the local health authority
patients who have a positive result on any laboratory test indicative of and
specific for detection of acute Chlamydophila psittaci infection.
2) Laboratories shall report and submit any Chlamydophila
psittaci positive results on serologic testing or culture from animals during
an individual case or outbreak investigation.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.595 Q-FEVER DUE TO COXIELLA BURNETII (REPORTABLE BY TELEPHONE AS SOON AS POSSIBLE, WITHIN 24 HOURS, UNLESS SUSPECT BIOTERRORIST EVENT OR PART OF AN OUTBREAK, THEN REPORTABLE IMMEDIATELY (WITHIN THREE HOURS) BY TELEPHONE)
Section 690.595 Q-fever Due
to Coxiella burnetii (Reportable by telephone as soon as possible, within 24
hours, unless suspect bioterrorist event or part of an outbreak, then
reportable immediately (within three hours) by telephone)
a) Control of Case
1) The local health authority should investigate cases to
determine history of contact with sheep, cattle or goats, parturient cats,
consumption of raw milk, or contact with laboratory cultures of Coxiella burnetii.
2) If multiple human cases occur in a geographic area and a
suspect animal source is identified, the Department will refer the information
to the Illinois Department of Agriculture.
b) Control of Contacts
No specific restrictions.
c) Laboratory Reporting
1) Laboratories
shall report to the local health authority patients who have a positive result
on any laboratory test indicative of or specific for detecting Coxiella burnetii
infection.
2) Laboratories
shall report and submit any Coxiella burnetii positive results on serologic
testing or culture from animals during an outbreak investigation.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.600 RABIES, HUMAN (REPORTABLE BY TELEPHONE, FACSIMILE, OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN 24 HOURS)
Section 690.600 Rabies,
Human (Reportable by telephone, facsimile, or electronically as soon as
possible, within 24 hours)
a) Control of Case
Cases of
suspect human rabies should be admitted to a health care facility.
b) Control of Contacts
Contacts who
have open wound or mucous membrane exposure to the case's saliva or central
nervous system fluid or tissue should receive rabies post-exposure prophylaxis
from a hospital emergency department or a health care provider.
c) Laboratory Reporting
1) Laboratories
shall immediately report to the local health authority by telephone all patients
for whom rabies testing has been requested.
2) The
Department's laboratory shall be contacted for instructions prior to the
shipment of specimens.
3) Laboratories
shall report to the local health authority by telephone patients who have a
positive result on any laboratory test indicative of or specific for detecting
acute rabies infection.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.601 RABIES, POTENTIAL HUMAN EXPOSURE AND ANIMAL RABIES (REPORTABLE BY TELEPHONE, FACSIMILE, OR ELECTRONICALLY, WITHIN 24 HOURS)
Section 690.601 Rabies,
Potential Human Exposure and Animal Rabies (Reportable by telephone, facsimile,
or electronically, within 24 hours)
a) Reporting of Rabies, Potential Human Exposure
Definition of
exposed person to be reported:
1) Any contact (bite or non-bite) to a bat; or
2) Any contact (bite or non-bite) from a rabies positive animal to
a person; or
3) Anyone who was started on rabies post-exposure prophylaxis; or
4) Anyone with exposure to saliva from a bite, or contact of any
abrasion or mucous membrane with brain tissue, saliva or cerebrospinal fluid from
a suspect rabid person or animal. Exposure to healthy rabbits, small rodents,
indoor-only domestic pets or rabies-vaccinated dogs, cats or ferrets is
excluded, unless:
A) the exposure complies with subsections (a)(1) through (a)(3);
or
B) the animal displays signs consistent with rabies; or
C) the bite occurred overseas; or
D) there is reason to suspect that rabies post exposure
prophylaxis might be or has been given; or
5) Any bite from a wild mammal, not including small rodents or
rabbits; or
6) Anyone who was in the same room as a bat and who might be
unaware that a bite or direct contact has occurred (e.g., a sleeping person
awakens to find a bat in the room or an adult witnesses a bat in the room with
a previously unattended child, mentally disabled person, or intoxicated person)
and rabies cannot be ruled out by testing the bat; or
7) Anyone bitten by a non-human primate or zoo animal.
b) Investigations
The local
health authority shall promptly investigate all known instances of potential
rabies exposure to determine whether rabies post-exposure prophylaxis for the
exposed person should be recommended.
c) Control of Biting Animals
See the Animal
Control Act.
d) Reporting Animal Rabies
Any positive animal
rabies test results shall be reported to both the Department and the Department
of Agriculture.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.605 RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION (LABORATORY CONFIRMED TESTING VIA ELR ONLY, PEDIATRIC DEATHS AND INTENSIVE CARE UNIT ADMISSIONS (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE, OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN 3 DAYS))
Section 690.605 Respiratory Syncytial Virus (RSV) Infection
(Laboratory Confirmed Testing via ELR only, Pediatric Deaths and Intensive Care
Unit Admissions (Reportable by mail, telephone, facsimile, or electronically as
soon as possible, within 3 days))
a) Control of Case
No specific restrictions.
b) Control of Cases
No specific restrictions.
c) The
death of a child younger than 18 years of age with laboratory-confirmed RSV
shall be reported (see Section 690.200 for mandated reporters and reporting
procedures). There should have been no period of recovery between illness and
death.
d) Laboratory
1) Laboratories
shall report all positive laboratory results for RSV to the Department via the
Department's electronic lab reporting (ELR) system in a manner and on a
schedule prescribed by the Department. Laboratories unable to submit results
to the Department via the Department's ELR shall contact the Department for
instructions on how to submit results.
2) Laboratories
shall forward to the Department's laboratory clinical materials that are
positive for RSV from RSV death cases younger than 18 years of age.
(Source: Amended at 48 Ill. Reg. 15900,
effective October 23, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.610 ROCKY MOUNTAIN SPOTTED FEVER (SEE TICKBORNE INFECTIONS)
Section 690.610 Rocky
Mountain Spotted Fever (See Tickborne Infections)
See Tickborne Infections
(Section 690.698).
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.620 RUBELLA (GERMAN MEASLES) (INCLUDING CONGENITAL RUBELLA SYNDROME) (REPORTABLE BY TELEPHONE, FACSIMILE, OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN 24 HOURS)
Section 690.620 Rubella
(German Measles) (Including Congenital Rubella Syndrome) (Reportable by
telephone, facsimile, or electronically as soon as possible, within 24 hours)
a) Control of Case
1) Rubella cases shall be isolated and avoid contact with
pregnant persons. If a pregnant person is exposed, a blood specimen should be
obtained and tested for rubella IgG specific and IgM specific antibodies.
2) Cases shall isolate themselves and be excluded from school,
child care facilities or the workplace for seven days after onset of the rash.
b) Control of Contacts
1) Susceptible contacts shall be excluded from school or the
workplace from days seven through 23 following rash onset after last exposure.
2) Susceptible health care workers exposed to rubella should
receive a dose of MMR vaccine. Susceptible exposed health care workers who do
not receive a dose of MMR and those that are vaccinated after exposure shall be
excluded from direct patient care for 23 days after the last exposure to
rubella, as no evidence exists that post-exposure vaccination is effective in
preventing rubella infection in persons already infected at the time of
vaccination.
c) Laboratory Reporting
Laboratories
shall report to the local health authority patients who have a positive result
on any laboratory test indicative of and specific for detecting rubella virus
infection.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.630 SALMONELLOSIS, INCLUDING PARATYPHI B VAR. L(+) TARTRATE+ (OTHER THAN S. TYPHI, S. PARATYPHI A, S. PARATYPHI B (TARTRATE NEGATIVE) AND S. PARATYPHI C CASES) (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE, OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN THREE DAYS)
Section 690.630
Salmonellosis, Including Paratyphi B var. L(+) tartrate+ (Other than S. Typhi,
S. Paratyphi A, S. Paratyphi B (tartrate negative) and S. Paratyphi C cases)
(Reportable by mail, telephone, facsimile, or electronically as soon as
possible, within three days)
a) Control of Case
1) Food
Handlers or Persons in Sensitive Occupations, Not Including Health Care Workers
Cases with salmonellosis (regardless
of the specimen source) shall not work as food handlers or in sensitive
occupations until diarrhea has ceased for at least 48 hours and two consecutive
negative stool specimens are obtained. Specimens shall be obtained following
clinical recovery of the patient, at least 24 hours apart and not sooner than
48 hours after the last dose of antimicrobials, if administered. Specimens
shall begin to be submitted within one week after notification.
2) Health
Care Workers
Local health authorities may
require specimens from health care workers or those who work in occupations
requiring standard precautions (regardless of the specimen source) if there is
reason to believe that specimen testing is necessary (e.g., the nature of the
work, including feeding patients, assisting patients with eating, providing or
preparing meals for patients, denture or oral care, hygienic practices of the
worker, dispensing or administering oral medications, or as part of an
investigation of a cluster). Specimens shall be obtained following clinical
recovery of the patient, at least 24 hours apart, and not sooner than 48 hours
after the last dose of antimicrobials, if administered. Specimens shall begin
to be submitted within one week after notification, or the individual shall be
restricted from patient care. When specimen submission is required, health care
workers who feed patients or assist patients with eating, provide or prepare meals
for patients, provide denture or oral care, or dispense or administer oral
medications, shall be restricted from these duties until two consecutive
negative stool specimens are obtained, or the public health authority
determines that monitoring is no longer warranted.
3) Cases
shall avoid swimming in public recreational water venues (e.g., swimming pools,
whirlpool spas, wading pools, water parks, interactive fountains, lakes) while
symptomatic and for two weeks after cessation of diarrhea.
b) Control of Contacts
1) Contacts Who Have Not Had Diarrhea During the Previous Four
Weeks
A) Food Handlers or Persons in Sensitive Occupations, Not
Including Health Care Workers
i) There
are no work restrictions while submitting release specimens for contacts who
are employed as food handlers or in sensitive occupations and who have had no
symptoms of Salmonella infection during the previous four weeks.
ii) Contacts
to cases of salmonellosis who are employed as food handlers or in sensitive
occupations shall submit two consecutive negative stool specimens obtained at
least 24 hours apart and not sooner than 48 hours after the last dose of
antimicrobials, if administered. These contacts shall be restricted from their
occupations if they do not begin submitting release specimens within one week
after notification. Release specimens shall be submitted at least once per week
until two consecutive negative specimens are obtained or the individuals shall
be restricted from working as food handlers.
iii) If
either of the two release specimens is positive for Salmonella, contacts shall
be considered cases and shall comply with subsection (a)(1).
B) Health
Care Workers. Local health authorities may require specimens from health care
workers or those who work in occupations requiring standard precautions if
there is reason to believe specimen testing is necessary (e.g., the nature of
the work, including feeding patients, assisting patients with eating, providing
or preparing meals for patients, denture or oral care, hygienic practices of
the worker, dispensing or administering oral medications, or as part of an
investigation of a cluster). Specimens shall be obtained at least 24 hours
apart. Specimens shall begin to be submitted within one week after
notification, or the individual shall be restricted from patient care.
2) Contacts Who Currently Have, or Have Had, Diarrhea During the
Previous Four Weeks
A) Food
Handlers or Persons in Sensitive Occupations, Not Including Health Care Workers
i) All
contacts to cases of salmonellosis employed as food handlers or in sensitive
occupations, and who currently have diarrhea or have had diarrhea during the
previous four weeks, shall not work in their occupations until diarrhea has
ceased for at least 48 hours and two consecutive negative stool specimens have
been obtained. Specimens shall be obtained following clinical recovery of the
patient, at least 24 hours apart and not sooner than 48 hours after the last
dose of antimicrobials, if administered. Specimens shall begin to be submitted
within one week after notification.
ii) If
either of the two release specimens is positive for Salmonella, contacts shall
be considered cases and shall comply with subsection (a)(1).
B) Health
Care Workers
Local health authorities may
require specimens from health care workers or those who work in occupations
requiring standard precautions if there is reason to believe that specimen
testing is necessary (e.g., the nature of the work, including feeding patients,
assisting patients with eating, providing or preparing meals for patients,
denture or oral care, hygienic practices of the worker, dispensing or
administering oral medications, or as part of an investigation of a cluster). Specimens
shall be obtained following clinical recovery of the patient, at least 24 hours
apart, and not sooner than 48 hours after the last dose of antimicrobials, if
administered. Specimens shall begin to be submitted within one week after
notification, or the individual shall be restricted from patient care. When
specimen submission is required, health care workers who feed patients or
assist patients with eating, provide or prepare meals for patients, provide
denture or oral care or dispense or administer oral medications, shall be
restricted from these duties until two culture negative stool specimens are
obtained, or the public health authority determines that monitoring is no
longer warranted.
c) Salmonella
Outbreaks at a Facility Where Food Handling Takes Place
When an outbreak occurs in a
facility where food handling occurs, food handlers at the facility shall be
considered contacts to cases and shall submit two consecutive negative stool
specimens obtained at least 24 hours apart and not sooner than 48 hours after
the last dose of antimicrobials, if administered. Local health authorities, in
consultation with the Department, may require two consecutive negative
specimens from food handlers at the facility before food handlers return to
work if there is reason to believe these individuals may be the source of the
illnesses or could transmit the disease. In all other outbreaks where there is
no reason to believe these individuals may be the source of the illness or
could transmit disease, food handlers shall be restricted from their
occupations if they do not begin submitting specimens within one week after
notification, and specimens shall be submitted at least once per week until two
consecutive negative specimens are obtained, or the individual shall be
restricted from food handling until the public health authority determines that
monitoring is no longer warranted.
d) Sale of Food, Milk, etc. (See Section 690.30(b).)
e) Laboratory Reporting
1) Laboratories shall report to the local health authority
patients from whom Salmonella has been isolated or patients who have a positive
result on any other laboratory test indicative of and specific for detecting
Salmonella infection.
2) Laboratories shall forward clinical materials positive for
Salmonella to the Department's laboratory in accordance with the Department's
specimen submission criteria.
3) Laboratories
shall report and submit to the Department's laboratory any Salmonella positive food,
environmental or animal samples resulting from an outbreak investigation or
upon request.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.635 SARS-COV-2 INFECTION (COVID-19) (LABORATORY CONFIRMED TESTING VIA ELR ONLY, PEDIATRIC DEATHS, AND INTENSIVE CARE UNIT ADMISSIONS) (REPORTABLE ELECTRONICALLY WITHIN THREE DAYS)
Section
690.635 SARS-CoV-2 Infection (COVID-19) (Laboratory Confirmed Testing via ELR
only, Pediatric Deaths, and Intensive Care Unit Admissions) (Reportable
electronically within three days)
a) Control of Cases
All cases shall isolate themselves at home per CDC
recommendations or as directed by the local health authority.
b) Control of Contacts
Contacts should monitor for illness, utilize source control
when around others per CDC recommendations and test as indicated to confirm
infection status.
c) Laboratory Reporting
1) Laboratories and other
facilities performing lab services that provide tests for screening, diagnosis,
or monitoring of COVID-19 disease shall report all positive laboratory results
for SARS-CoV-2 infection, including, but not limited to, all molecular and
antigen to the Department via the Department's electronic lab reporting (ELR)
system in a manner and on a schedule prescribed by the Department (see Section
690.200 (a)(4) and (5)). Laboratories unable to submit results to the
Department via the Department's ELR shall contact the Department for
instructions on how to submit results.
2) If deemed necessary by the
Department or local health authority, laboratories shall forward clinical
specimens to the Department's laboratory for further testing.
(Source: Former Section 690.635 repealed at 44 Ill. Reg.
20145, effective December 9, 2020; new Section 690.635 added at 48 Ill. Reg. 4098,
effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.640 SHIGELLOSIS (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE, OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN THREE DAYS)
Section 690.640 Shigellosis
(Reportable by mail, telephone, facsimile, or electronically as soon as
possible, within three days)
a) Control of Case
1) Food
Handlers or Persons in Sensitive Occupations, Not Including Health Care Workers
Cases with shigellosis (regardless
of the specimen source) shall not work as food handlers or in sensitive
occupations until diarrhea has ceased for at least 48 hours and two consecutive
negative stool specimens are obtained. Specimens shall be obtained following
clinical recovery of the patient, at least 24 hours apart and not sooner than
48 hours after the last dose of antimicrobials, if administered. Specimens
shall begin to be submitted within one week after notification.
2) Health
Care Workers
Local health authorities may
require specimens from health care workers or those who work in occupations
requiring standard precautions if there is reason to believe that specimen
testing is necessary (e.g., the nature of the work, including feeding patients,
assisting patients with eating, providing or preparing meals for patients,
denture or oral care, hygienic practices of the worker, dispensing or
administering oral medications, or as part of an investigation of a cluster). Specimens
shall be obtained following clinical recovery of the patient, at least 24 hours
apart, and not sooner than 48 hours after the last dose of antimicrobials, if
administered. Specimens shall begin to be submitted within one week after
notification, or the individual shall be restricted from patient care. When
specimen submission is required, health care workers who feed patients or
assist patients with eating, provide or prepare meals for patients, provide
denture or oral care, or dispense or administer oral medications, shall be
restricted from these duties until two negative stool specimens are obtained or
the local health department determines that monitoring is no longer warranted.
3) Day Care Attendees
Cases of Shigella shall be
excluded from attending a child care facility, an adult day care facility, or a
facility for the developmentally disabled if below five years of age or
incontinent of stool until the case has been symptom free for 24 hours. Local
health authorities may require more strict requirements, such as release
specimens before returning to day care, if the local health department
determines it is necessary to prevent the spread of infection.
4) Cases
shall avoid swimming in public recreational water venues (e.g., swimming pools,
whirlpool spas, wading pools, water parks, interactive fountains, lakes) while
symptomatic, and for two weeks after cessation of diarrhea.
b) Control of Contacts
1) Contacts Who Have Not Had Diarrhea during the Previous Four
Weeks
A) Food
Handlers or Persons in Sensitive Occupations, Not Including Health Care Workers
i) There
are no work restrictions while submitting release specimens for contacts who
are employed as food handlers or in sensitive occupations and who have had no
symptoms of Shigella infection during the previous four weeks.
ii) Contacts
to cases of shigellosis who are employed as food handlers or in sensitive
occupations shall submit two consecutive negative stool specimens obtained at
least 24 hours apart and not sooner than 48 hours after the last dose of
antimicrobials, if administered. These contacts shall be restricted from their
occupations if they do not begin submitting release specimens within one week
after notification. Release specimens shall be submitted at least once per week
until two consecutive negative specimens are obtained or the individual shall
be restricted from working as food handlers.
iii) If
either of the two release specimens is positive for Shigella, contacts shall be
considered cases and shall comply with subsection (a)(1).
B) Health
Care Workers
Local health authorities may
require specimens from health care workers or those who work in occupations
requiring standard precautions if there is reason to believe that specimen
testing is necessary (e.g., the nature of the work, including feeding patients,
assisting patients with eating, providing or preparing meal for patients,
denture or oral care, hygienic practices of the worker, dispensing or
administering oral medications, or as part of an investigation of a cluster). Specimens
shall be obtained at least 24 hours apart. Specimens shall begin to be
submitted within one week after notification, or the individual shall be
restricted from patient care.
2) Contacts Who Currently Have, or Have Had, Diarrhea during the
Previous Four Weeks
A) Food Handlers or Persons in Sensitive Occupations, Not
Including Health Care Workers
i) All
contacts to cases of shigellosis employed as food handlers or in sensitive
occupations, and who currently have diarrhea or have had diarrhea during the
previous four weeks, shall not work in their occupations until diarrhea has
ceased for at least 48 hours and they have submitted two consecutive negative
stool specimens. Specimens shall be obtained following clinical recovery of
the patient, at least 24 hours apart and not sooner than 48 hours after the
last dose of antimicrobials, if administered. Specimens shall begin to be
submitted within one week after notification.
ii) If
either of the two release specimens is positive for Shigella, contacts shall be
considered cases and shall comply with subsection (a)(1).
B) Health
Care Workers
Local health authorities may
require specimens from health care workers or those who work in occupations
requiring standard precautions if there is reason to believe that specimen
testing is necessary (e.g., the nature of the work, including feeding patients,
assisting patients with eating, providing or preparing meals for patients,
denture or oral care, hygienic practices of the worker, dispensing or
administering oral medications, or as part of an investigation of a cluster). Specimens
shall be obtained following clinical recovery of the patient, at least 24 hours
apart, and not sooner than 48 hours after the last dose of antimicrobials, if
administered. Specimens shall begin to be submitted within one week after
notification, or the individual shall be restricted from patient care. When
specimen submission is required, health care workers who feed patients or
assist patients with eating, provide or prepare meals for patients, provide
denture or oral care, or dispense or administer oral medications, shall be
restricted from these duties until two culture negative specimens are obtained
or if the public health authority determines that monitoring is no longer
warranted.
c) Shigella Outbreaks at a
Facility Where Food Handling Takes Place
When an outbreak occurs in a
facility where food handling occurs, food handlers at the facility shall be
considered contacts to cases, and shall submit two consecutive negative stool
specimens obtained at least 24 hours apart and not sooner than 48 hours after
the last dose of antimicrobials, if administered. Local health authorities, in
consultation with the Department, may require two consecutive negative
specimens from food handlers at the facility before food handlers return to
work if there is reason to believe these individuals may be the source of the
illnesses or could transmit disease. In all other outbreaks where there is no
reason to believe these individuals may be the source of the illness or could
transmit disease, food handlers shall be restricted from their occupations if
they do not begin submitting specimens within one week after notification, and
specimens shall be submitted at least once per week until two consecutive
negative specimens are obtained, or the individual shall be restricted from
food handling.
d) Sale of Food, Milk, etc. (See Section 690.30(b).)
e) Laboratory Reporting
1) Laboratories shall report to the local health authority
patients from whom Shigella has been isolated or patients who have a positive
result on any laboratory test indicative of and specific for detecting Shigella
infection and antibiotic susceptibility test results.
2) Laboratories shall forward clinical materials positive for
Shigella to the Department's laboratory in accordance with the Department's
specimen submission criteria.
3) Laboratories shall report and submit to the Department's
laboratory any Shigella-positive food or environmental samples resulting from
an outbreak investigation.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.650 SMALLPOX (REPORTABLE BY TELEPHONE IMMEDIATELY, WITHIN THREE HOURS UPON INITIAL CLINICAL SUSPICION OF THE DISEASE)
Section 690.650 Smallpox
(Reportable by telephone immediately, within three hours upon initial
clinical suspicion of the disease)
a) Control of Case
Cases shall be
admitted to a health care setting.
b) Control
of Contacts
Post-exposure immunization, within
three to four days after exposure, provides some protection against disease and
significant protection against a fatal outcome. It is recommended that any
person with significant exposure to a person with probable or confirmed smallpox
during the infectious stage of illness be immunized as soon after exposure as
possible, within the first four days after exposure.
c) Sale of Food, Milk, etc. (See Section 690.30(b).)
d) Laboratory
Reporting
1) Laboratories shall immediately report to the local health
authority all persons for whom smallpox testing has been requested.
2) Laboratories shall immediately report to the local health
authority accidental laboratory exposures, injuries or infections in a
laboratory worker working with smallpox vaccine or specimens.
3) Laboratories shall contact the Department for instructions
prior to the shipment of specimens.
4) Laboratories
shall report to the local health authority patients who have a positive result
on any laboratory test indicative of and specific for detecting smallpox
infection.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.655 SMALLPOX VACCINATION, COMPLICATIONS OF (REPORTABLE BY TELEPHONE OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN 24 HOURS) (SEE SMALLPOX)
Section 690.655 Smallpox vaccination, complications of
(Reportable by telephone or electronically as soon as possible, within 24
hours) (See Smallpox)
See Smallpox (Section 690.650).
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: COMMUNICABLE DISEASE CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF COMMUNICABLE DISEASES CODE
SECTION 690.658 STAPHYLOCOCCUS AUREUS, METHICILLIN RESISTANT (MRSA) INFECTION, CLUSTERS OF TWO OR MORE LABORATORY CONFIRMED CASES OCCURRING IN COMMUNITY SETTINGS (INCLUDING, BUT NOT LIMITED TO, SCHOOLS, CORRECTIONAL FACILITIES, DAY CARE AND SPORTS TEAMS) (REPORTABLE BY TELEPHONE OR FACSIMILE AS SOON AS POSSIBLE, WITHIN 24 HOURS) (REPEALED)
Section
690.658 Staphylococcus aureus, Methicillin Resistant (MRSA) Infection,
Clusters of Two or More Laboratory Confirmed Cases Occurring in Community
Settings (Including, but Not Limited to, Schools, Correctional Facilities, Day
Care and Sports Teams) (Reportable by telephone or facsimile as soon as
possible, within 24 hours) (Repealed)
(Source: Repealed at 43 Ill.
Reg. 2386, effective February 8, 2019)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: COMMUNICABLE DISEASE CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF COMMUNICABLE DISEASES CODE
SECTION 690.660 STAPHYLOCOCCUS AUREUS, METHICILLIN RESISTANT (MRSA), ANY OCCURRENCE IN AN INFANT LESS THAN 61 DAYS OF AGE (REPORTABLE BY TELEPHONE OR FACSIMILE AS SOON AS POSSIBLE, WITHIN 24 HOURS) (REPEALED)
Section 690.660
Staphylococcus aureus, Methicillin Resistant (MRSA), Any
Occurrence in an Infant Less Than 61 Days of Age (Reportable by telephone or facsimile
as soon as possible, within 24 hours) (Repealed)
(Source: Repealed at 43 Ill.
Reg. 2386, effective February 8, 2019)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.661 STAPHYLOCOCCUS AUREUS INFECTIONS WITH INTERMEDIATE (MINIMUM INHIBITORY CONCENTRATION (MIC) BETWEEN 4 AND 8) (VISA) OR HIGH-LEVEL RESISTANCE TO VANCOMYCIN (MIC GREATER THAN OR EQUAL TO 16) (VRSA) (REPORTABLE BY TELEPHONE, FACSIMILE, OR ELECTRONICALLY WITHIN THREE DAYS)
Section 690.661
Staphylococcus aureus Infections with Intermediate (Minimum
inhibitory concentration (MIC) between 4 and 8) (VISA) or High-Level Resistance
to Vancomycin (MIC greater than or equal to 16) (VRSA) (Reportable by telephone,
facsimile, or electronically within three days)
a) Control of Case
No specific restrictions.
b) Control
of Contacts
The Department will issue specific
recommendations on a case-by-case basis based on factors such as the setting in
which the exposure occurred and the risk of other patients or residents
developing severe disease.
c) Laboratory Reporting
1) Laboratories shall report to the local health authority
patients from whom VISA (MIC between 4 and 8) or VRSA (MIC greater than or
equal to 16) has been isolated regardless of method.
2) Laboratories shall forward clinical materials with a
vancomycin minimum inhibitory concentration greater than or equal to 8 to the
Department's laboratory.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.670 STREPTOCOCCAL INFECTIONS, GROUP A, INVASIVE DISEASE (INCLUDING STREPTOCOCCAL TOXIC SHOCK SYNDROME AND NECROTIZING FASCIITIS) IN PERSONS IN HOSPITALS OR RESIDING IN A RESIDENTIAL FACILITY, INCLUDING ANTIBIOTIC SUSCEPTIBILITY TEST RESULTS (REPORTABLE BY TELEPHONE, FACSIMILE, OR ELECTRONICALLY WITHIN 24 HOURS)
Section 690.670
Streptococcal Infections, Group A, Invasive Disease (Including Streptococcal
Toxic Shock Syndrome and Necrotizing fasciitis) In Persons in Hospitals or
Residing in a Residential Facility, including antibiotic susceptibility test
results (Reportable by telephone, facsimile, or electronically within 24 hours)
a) Control of Case
1) No specific restrictions.
2) Health care facilities shall comply with local health
authority recommendations for control measures supported by the Department or
CDC procedures and best practices recommended for various healthcare settings for
control of transmission.
b) Control of Contacts
1) Health care facilities shall comply with local health
authority recommendations for control measures and outbreak response as
supported by the Department or CDC procedures and best practices recommended
for various healthcare settings for control of transmission.
2) Culture of symptomatic contacts and culturing asymptomatic
contacts should be considered.
c) Laboratory Reporting
Laboratories
shall retain specimens for up to 30 days and forward clinical materials to the
Department's laboratory upon request.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: COMMUNICABLE DISEASE CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF COMMUNICABLE DISEASES CODE
SECTION 690.675 STREPTOCOCCAL INFECTIONS, GROUP B, INVASIVE DISEASE, OF THE NEWBORN (BIRTH TO 3 MONTHS) (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE OR ELECTRONICALLY, WITHIN 7 DAYS) (REPEALED)
Section 690.675
Streptococcal Infections, Group B, Invasive Disease, of the Newborn (birth to 3
months) (Reportable by mail, telephone, facsimile or electronically, within 7
days) (Repealed)
(Source: Repealed at 32 Ill.
Reg. 3777, effective March 3, 2008)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.678 STREPTOCOCCUS PNEUMONIAE, INVASIVE DISEASE IN CHILDREN YOUNGER THAN 5 YEARS (INCLUDING ANTIBIOTIC SUSCEPTIBILITY TEST RESULTS) (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE, OR ELECTRONICALLY, WITHIN THREE DAYS)
Section 690.678 Streptococcus
pneumoniae, Invasive Disease in Children Younger than 5 Years (Including
Antibiotic Susceptibility Test Results) (Reportable by mail, telephone,
facsimile, or electronically, within three days)
a) Control of Case
No specific
restrictions.
b) Control of Contacts
No specific restrictions.
c) Laboratory Reporting
Laboratories shall
report to the local health authority patients younger than 5 years of age from
whom Streptococcus pneumoniae has been isolated from a normally sterile site.
The antibiotic susceptibility test results shall also be reported.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: COMMUNICABLE DISEASE CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF COMMUNICABLE DISEASES CODE
SECTION 690.680 SYPHILIS (REPEALED)
Section 690.680 Syphilis
(Repealed)
(Source: Repealed at 12 Ill. Reg. 10045, effective May 27, 1988)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.690 TETANUS (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE, OR ELECTRONICALLY, WITHIN THREE DAYS)
Section 690.690 Tetanus
(Reportable by mail, telephone, facsimile, or electronically, within three
days)
a) Control of Case
No specific
restrictions.
b) Control of Contacts
No
restrictions.
c) Laboratory Reporting
Laboratories
shall report to the local health authority patients who
have positive results on any laboratory test indicative of and specific for
detecting tetanus infection, including all isolates of Clostridium tetani.
(Source: Amended at 48 Ill.
Reg. 4098, effective February 27, 2024)
| TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: NOTIFIABLE DISEASES AND CONDITIONS CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE
SECTION 690.695 TOXIC SHOCK SYNDROME DUE TO STAPHYLOCOCCUS AUREUS INFECTION (REPORTABLE BY MAIL, TELEPHONE, FACSIMILE, OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN THREE DAYS)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
